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3ABSTRACT
New organotypic liver cell cultures are needed to predict the metabolism,
excretion,  and  safety  of  chemical  compounds.  Liver  cell  models  are
particularly  important  since  the  liver  largely  regulates  the  ultimate  fate  of
compounds in the body. Approximately 70% of the drugs administered to the
body are metabolized or excreted by the liver.
Animal  models,  cell  cultures,  and  cell-free  assays  are  the  most  common
liver models. However, animal models and animal cells do not represent
humans due to the interspecies differences in drug metabolizing enzymes
and transporters. Instead, the most common cell-free methods, microsomes,
are  appropriate  for  drug  metabolism  studies,  but  the  lack  of  drug
transporters and transcription machinery prevents the complete evaluation
of  compounds.  Primary  human  hepatocytes  are  capable  of  both  drug
metabolism  and  drug  transport,  and  are,  therefore,  considered  the  gold
standard to assess metabolism and toxicity of  compounds in vitro. Primary
hepatocytes, however, suffer limited availability, high functional variability,
and difficulty with maintaining differentiated phenotypes and functions in
cell cultures. Therefore, continuous human liver cell lines, such as HepG2
and HepaRG, have been widely used to evaluate drugs and chemicals even
though they have defects in their biotransformation functions. The
advantages of cell lines are their good availability, easy maintenance, and
inducible drug metabolism.
Generally, these cells are cultured in a two-dimensional (2D) manner that
deviates from the physiological morphology and functions of the hepatocytes.
The  flattened  2D  phenotype  leads  to  reduced  polarization  and  loss  of
important  signaling  pathways;  this  is  likely  to  be  a  major  reason  for  the
failure  in  the  prediction  of  drug  metabolism,  pharmacokinetics,  and
hepatotoxicity. It is believed that for more predictive in vitro models,  the
liver  cells  should  be  maintained  in  a  three-dimensional  (3D)
microenvironment  that  allows  reconstruction  of  polarization,  and  cell-cell
and cell-extracellular matrix (ECM) contacts. The 3D cell cultures have been
generated  by  different  methods,  such  as  cultures  in  matrices,  scaffolds,
bioreactors, and microfluidic platforms. Biomaterial hydrogels have
demonstrated great potential for 2D liver cell culturing, but their potential to
generate functional 3D liver cell cultures is largely unknown.
The  main  goal  of  this  thesis  was  to  establish  improved  3D  liver  cell
cultures with biomaterial hydrogels. Particular attention was focused on the
effects of 3D hydrogels on drug metabolism and excretion, cytoarchitecture,
and  cellular  differentiation  of  HepG2  and  HepaRG  cell  lines.  As  a  starting
point,  we  studied  the  suitability  of  wood-derived  nanofibrillar  cellulose
(NFC) hydrogel as a cell culture matrix. NFC hydrogel has not been studied
in cell culture before; however, as a novel, defined, animal-free, and
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wood-derived NFC was proven to own rheological and structural characters
that  allow  3D  cell  culture.  Moreover,  the  NFC  was  compatible  with  the
HepG2  and  HepaRG  cells,  allowing  for  the  formation  of  3D  multicellular
aggregates  with  increased  apicobasal  polarity.  When  compared  to
commercial  hydrogels,  the  NFC  supported  the  albumin  secretion,  an
indicator of hepatocellular synthetic function, from HepG2 and HepaRG cells
as well or even better. These results demonstrate the potential of wood-
derived NFC to function as an ECM analogue, and present the first HepaRG
aggregate cultures.
Next,  the  effect  of  the  RAD16-I  peptide  hydrogel  on  the  HepG2 cell  line
was investigated in more detail. Immunofluorescence staining and vectorial
transport  showed  formation  of  tissue-like  arrangements  including  bile
canaliculi-like structures and polar distribution of canalicular efflux
transporters, multidrug resistance-associated protein 2 (MRP2), and
multidrug  resistance  protein  1  (MDR1),  in  the  spherical  HepG2  cell
aggregates. The study clearly demonstrated that the peptide hydrogel
increases the apicobasal polarity and appearance of bile canaliculi structures
in HepG2 cell cultures.
The plasticity of HepaRG liver cells was exploited to investigate the
impact  of  3D  NFC  and  hyaluronan-gelatin  (HG)  hydrogel  cultures  on  the
phenotype of both undifferentiated HepaRG cells (early liver progenitors)
and differentiated HepaRG cells (hepatocyte-like cells together with
cholangiocyte-like  cells).  Based  on  the  expression  and  activity  of  hepatic
markers, drug metabolizing enzymes, and drug transporters, the 3D NFC and
HG hydrogels promoted the differentiation of HepaRG liver progenitor cells
when compared to the standard 2D technique. Instead, the 3D hydrogel
cultures could not really improve the properties of differentiated HepaRG
cells.
In  conclusion,  these  findings  reveal  the  capability  of  the  NFC,  RAD16-I
peptide, and HG hydrogels to improve the properties of HepG2 and HepaRG
human  liver  cells.  The  new  spheroid  cultures  of  HepG2  and  HepaRG  cells
may represent added value for pharmacokinetic and toxicity predictions,
showing a liver-like cytoarchitecture and demonstrating applicability for
drug  metabolism  and  transport  studies.  Overall,  the  results  deepen  our
knowledge of the 3D liver cell cultures.
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ABBREVIATIONS
2D Two-dimensional
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ABCB1 ATP-binding  cassette  sub-family  B  member  1,  also  known  as
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ABCB11  ATP-binding  cassette  sub-family  B  member  11,  also  known  as
Bile Salt Export Pump (BSEP)
ABCC2 ATP-binding  cassette  sub-family  C  member  2,  also  known  as
Multidrug resistance-associated protein 2 (MRP2)
ABCG2 ATP-binding  cassette  sub-family  G  member  2,  also  known  as
Breast cancer resistance protein
BCRP Breast cancer resistance protein, also known as ATP-binding
cassette sub-family G member 2
BSEP Bile salt export pump, also known as ATP-binding cassette sub-
family B member 11 (ABCB11)
CAR constitutive androstane receptor
CLh Drug clearance occurring in the liver, also known as hepatic
clearance
CLr Drug clearance occurring in the kidney, also known as renal
clearance
CYP Cytochrome P450
DMSO Dimethyl sulfoxide
ECM Extracellular matrix
ELISA Enzyme-linked immunosorbent assay
EMA European Medicines Agency
FDA Food and Drug Administration
FMO Flavin-containing monooxygenase
GST Glutathione S-transferase
HA Hyaluronan, hyaluronic acid
HCS High-content screening
HG Hyaluronan-gelatin
HNF Hepatocyte nuclear factor
HTS High-throughput screening
iPSC induced pluripotent stem cell
KRT19 Keratin 19
MATE1 Multidrug  and  toxin  extrusion  protein  1,  also  known  as  solute
carrier family 47 member 1 (SLCO47A1)
MCT Monocarboxylate transporter
MDR1 Multidrug resistance protein 1, also known as P-glycoprotein and
ATP-binding cassette sub-family B member 1
MRP Multidrug resistance-associated protein sub-family
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MRP2 Multidrug  resistance-associated  protein  2,  also  known  as  ATP-
binding cassette sub-family C member 2 (ABCC2)
NAT N-acetyltransferase
NFC Nanofibrillar Cellulose
NTCP Na+ -taurocholate cotransporting polypeptide
OCT Organic cation transporter
OATP Organic anion transporting polypeptide, also known as Solute
carrier organic anion transporter (SLCO)
PCR Polymerase chain reaction
PEG Poly(ethylene glycol)
PGA Poly(glycolic acid)
PLA Poly(lactic acid)
PLGA poly(lactic-co-glycolic acid)
PXR Pregnane X receptor
REACH  Registration, Evaluation, Authorisation and Restriction of
Chemicals
SLCO Solute carrier organic anion transporter, also known as Organic
anion transporting polypeptide
SULT Sulfotransferase
UGT Uridine Glucuronide Transferase
US United States
UV ultraviolet
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1 INTRODUCTION
Drug  discovery  and  development  is  a  complicated  process  that  takes  an
average of 10–15 years. The entire process is comprised of several stages
from target identification through preclinical studies to clinical trials in
humans. Only 10% of the compounds that enter clinical trials qualify through
the  process  and  reach  the  market  (Bunnage,  2011;  Castellani,  2011).  This
means that preclinical studies are not able to properly predict the behavior of
novel  compounds  in  the  human  body.  Especially,  the  predictive  ability  and
reproducibility of preclinical tests need improvement (Mandenius et al.,
2011; Begley and Ellis, 2012; Henderson et al., 2013).
Animal experiments do not mirror humans due to the interspecies
differences in drug biotransformation and, therefore, may fail to predict the
drug´s  safety  or  effectiveness  (Dash  et  al.,  2012;  Pfeifer  et  al.,  2014).  The
validity of  the current in vitro models is not high either. Genetic variations
between the donors and the loss of  polarized architecture together with the
loss  of  appropriate  functions  decrease  the  reproducibility  and  predictive
power of primary human cells (Hewitt et al., 2007; Hewitt, 2010; Sahi et al.,
2010).  Further,  the  short  lifetime  of  primary  human  cells  in  the  culture
prevents long-term experiments. Cell lines offer more stable models, but
generally,  the  data  cannot  be  extrapolated  to  humans  as  the  drug
biotransformation differs from the native human cells (Anene-Nzelu et al.,
2011; Dash et al., 2012). In addition, cell-free systems have been revealed as
too simplified to predict the in vivo safety and effectiveness of drugs (Jia and
Liu, 2007; Hillgren et al., 2013).
Innovations are clearly needed to develop more reliable preclinical tests.
In fact,  the Food and Drug Administration (FDA) of  the United States (US)
has  emphasized  the  need  for  improved  preclinical  cell  models  for  drug
development in their  “Critical  Path Initiative” (US FDA, 2004, 2010),  while
the European Union (EU) has supported several research projects to
establish new in vitro models for investigating human drug metabolism and
toxicology properties of  compounds.  The need for new preclinical models is
further  increased  by  the  recent  chemical  safety  regulation  that  the  EU
released in 2007 (European Parliament and Council, 2006; European
Chemicals  Agency,  2009).  The “Registration,  Evaluation,  Authorisation and
Restriction of Chemicals (REACH)” regulation requires that the safety
properties of all chemicals that are manufactured and marketed in the EU be
assessed and collected. This means that the effects and safety of
approximately 140,000 chemical substances must be tested (European
Chemicals Agency, 2008). Especially interesting is that the REACH promotes
alternative methods for the assessment of chemical safety in order to reduce
the number of animal tests.
Introduction
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Liver models are particularly important for drug discovery and chemical
testing since the ultimate fate of  drugs and chemicals  in the body is  largely
regulated by hepatic uptake, metabolism, and excretion. Approximately 65%
of  drugs  are  predominantly  eliminated  by  metabolism  in  the  liver,  and  an
additional 6% of drugs are eliminated by excretion to the bile (Williams et al.,
2004;  RxList,  2012).  Liver  parenchymal  cells,  hepatocytes,  carry  out  drug
elimination with their metabolizing enzymes and membrane transporters.
The  metabolizing  enzymes  convert  the  compounds  to  the  metabolites  that
can be more easily excreted from the body, whereas membrane transporters
are  responsible  for  the  vectorial  transport  through  the  hepatocyte  cell
membranes, thereby enabling drug elimination from the blood circulation to
the  bile.  To  predict  vectorial  drug  elimination  in  humans,  the  liver  model
should comprise polarized cells and express both metabolizing enzymes and
transporters at the correct cellular positions at relevant levels.
Human  hepatocyte  cultures  and  human  liver  microsomes  are  well-
accepted in vitro test systems. They are used to predict in vivo human drug
metabolism  (US  FDA,  2012),  but  the  prediction  of  drug  transport  has  not
been  satisfactory  (Giacomini  et  al.,  2010).  Also  the  prediction  of  human
hepatotoxicity  remains  very  challenging  (EMA,  2008).  This  failure  may
result from the fact that the current methods are based on two-dimensional
(2D) hepatocyte cultures, where cells grow as a monolayer on a flat surface.
These cells do not represent either the structure or the functions of the three-
dimensional (3D) liver tissue (Bissell  et  al.,  2005;  Pampaloni  et  al.,  2009).
Therefore, novel cell culturing techniques for liver cells need to be developed.
Particularly,  3D  cell  culture  methods  have  raised  interest,  since  they  may
offer better  prospects for modelling of  liver tissue by increased cell-cell  and
cell-extracellular matrix (ECM) signaling properties (Mandenius et al., 2011;
LeCluyse et al., 2012; Godoy et al., 2013).
This  thesis  aimed  to  develop  3D  liver  cell  cultures  that  mimic  the
polarized  cellular  structure  and  drug  elimination  functions  of  the  liver.  The
3D  culturing  environment  was  generated  with  hydrogels  based  on
nanofibrillar cellulose (NFC), peptide nanofibers, and block copolymers.
Review of the literature
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2 REVIEW OF THE LITERATURE
2.1 THE ROLE OF THE LIVER IN DRUG METABOLISM
AND EXCRETION
The  liver  plays  an  essential  role  in  the  human  body  being  responsible  for
metabolizing  and  excreting  of  endogenous  and  exogenous  solutes.  In
addition,  the liver produces bile,  urea,  and the majority of  plasma proteins,
and  controls  the  homeostasis  of  glucose,  glycogen,  and  cholesterol.  To  be
capable  of  performing  all  these  functions,  the  liver  has  a  high  blood  supply
from both the hepatic artery and the hepatic portal vein, and is composed of
functionally different zones and cell types (Figs. 1 and 3). Parenchymal cells
(hepatocytes)  represent  almost  80%  of  the  liver´s  total  volume,  and  non-
parenchymal cells, such as sinusoidal endothelial cells, Kupffer cells, and
biliary  epithelial  cells  (i.e.  cholangiocytes)  contribute  approximately  10% of
the  total  volume  (Kmiec,  2001).  The  remaining  10%  of  the  liver  volume
consists  of  extracellular  space  compartments,  such  as  sinusoids  (the
capillaries of the liver) and bile canaliculi.
Figure 1 The architecture of a liver functional unit. The central structure is the central vein,
which is radially surrounded by liver parenchymal cells i.e. hepatocytes (beige),
sinusoidal capillaries i.e. sinusoids (blue), and bile canaliculi (yellow-green). The
unit receives blood from the hepatic portal vein and the hepatic artery from where
the blood flows through sinusoids to the central vein. The bile, secreted by
hepatocytes, flows to the opposite direction than the blood, from bile canaliculi to
the bile duct. The image is modified from (LeCluyse et al., 2012).
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2.1.1 METABOLISM AND EXCRETION OF DRUGS IN THE LIVER
The liver is  the major organ of  drug elimination.  Approximately 65% of  the
drugs administered to the body are metabolized in the liver (RxList, 2012). In
addition,  about  6%  of  drugs  are  eliminated  through  biliary  excretion.  The
rest of the drugs are eliminated predominantly through renal excretion (25%)
or are metabolized/excreted elsewhere in the body (4%). Because drugs are
predominantly metabolized in the liver or excreted in the urine and bile, drug
elimination (total body clearance) is described as a summary of the drug
clearance  occurring  in  the  liver  (CLh)  and  the  kidney  (CLr)  (Rowland  and
Tozer, 2011).
Hepatic  clearance  (CLh)  is  a  complex  process  that  depends  on  passive
drug  diffusion  into  the  hepatocytes,  drug  metabolism  by  the  enzymes,  and
drug  transporting  activity  of  the  membrane  transporters  (Fig.  2).  (1)  The
drug enters the hepatocyte either by passive diffusion across the sinusoidal
plasma  membrane  or  by  active  transport  via  uptake  transporters  at  the
sinusoidal  plasma membrane.  (2)  Conversion  of  the  drug  to  the  metabolite
takes  place  within  the  hepatocytes  by  phase  I  and  II  reactions.  Phase  I
enzymes  catalyze  the  formation  of  a  functional  group  or  cleavage  (e.g.,
oxidation,  reduction,  hydrolysis),  and  phase  II  enzymes  induce  drug
conjugation with an endogenous substance (e.g., glucuronidation and
sulfation).  In  general,  drug  metabolites  are  more  hydrophilic  compounds
than  the  parent  drug  and  cannot  enter  the  plasma  membrane  easily.  (3)
Instead, hydrophilic metabolites may be actively transported from the inside
of the hepatocyte to the bile or the blood by efflux transporters located at the
canalicular and basolateral membranes, respectively (Fig. 2). The metabolites
that are excreted to the blood are effectively excreted through the urine due
to their reduced re-absorption in the kidney.
The roles of the phase I and II metabolizing enzymes in drug elimination
has been known for decades. On the contrary, the clinical importance of drug
uptake  transporters  and  drug  efflux  transporters  is  only  currently  being
revealed (Giacomini et al., 2010; EMA, 2012; Hillgren et al., 2013). The best-
known transporter, P-glycoprotein (P-gp, MDR1, ABCB1) was discovered in
the  1970s  (Juliano  and  Ling,  1976),  but  its  role  in  pharmacokinetics  and
drug-drug interactions was understood later. P-glycoprotein, which belongs
to the ATP-binding cassette (ABC) superfamily, acts as an efflux transporter
at the canalicular membrane of the liver. The other transporters of emerging
importance include: canalicular efflux transporters, multidrug resistance-
associated protein 2 (MRP2, ABCC2), breast cancer resistance protein
(BCRP, ABCG2), bile salt export pump (BSEP, ABCB11), and multidrug and
toxin extrusion protein 1 (MATE1, SLC47A1), and sinusoidal uptake
transporters, organic anion transporting polypeptide 1B1 (OATP1B1,
SLCO1B1), organic anion transporting polypeptide 1B3 (OATP1B3,
SLCO1B3), and organic anion transporting polypeptide 2B1 (OATP2B1,
SLCO2B1) (Hillgren et al., 2013).
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Figure 2 Schematic diagram of drug transport and metabolism in the hepatocytes.
Hepatocytes receive endogenous and exogenous substances from the blood and
can convert these compounds, such as drugs, to the metabolites that are excreted
to the bile or back to the blood. The substances enter and exit the hepatocytes by
passive diffusion or active transport. Uptake transporters (e.g. OATP) locate at the
sinusoidal membrane and efflux transporters both at the canalicular and sinusoidal
membranes (e.g. MDR1, MRP2, MRP3).
2.1.2 THE IMPORTANCE OF HEPATOCYTE ARCHITECTURE
For drug metabolism and excretion, the hepatocytes must be well-organized
and polarized. The plasma membrane of the hepatocyte consists of
structurally distinct domains: sinusoidal, lateral, and bile canalicular
(Hubbard  et  al.,  1983)  (Fig.  2).  The  sinusoidal  domain  faces  blood  vessels,
whereas the lateral and bile canalicular domains face the adjacent
hepatocytes.  The  bile  canalicular  domain  is  separated  from  the  lateral
domain by tight junctions and expresses a different function than the lateral
domain (Fig. 2). All the domains express different transporter proteins and
are functionally very different, enabling transcellular vectorial transport from
the  blood  to  the  bile.  The  sinusoidal  membrane  mediates  an  intense  solute
transfer with blood plasma, whereas the lateral membranes are specialized
for cell attachments, cell-cell communication, and function as barriers
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between the sinusoidal and the canalicular domains, while the canalicular
membranes secrete bile to the canaliculi (Jansen, 2000). The bile canaliculi
functions also as a pathway for the excretion of endogenous wastes and drug
metabolites.
2.1.3 REGULATION OF HEPATOCYTE PHENOTYPE
Hepatocytes  are  subject  to  signals  from  each  other,  other  cell  types,  blood
and bile  flow, and ECM. The biochemical  and mechanical  signals  direct  the
polarity,  expression  patterns,  and  functions  of  hepatocytes  (Fig.  3).  The
direct physical contact between the cells is known to maintain the hepatocyte
polarity  and  the  normal  phase  I  metabolism  (Hamilton  et  al.,  2001).  The
soluble signals enable the communication between the non-parenchymal
cells and the hepatocytes in the liver. For example, the non-parenchymal
cells can mediate induction of the efflux transporters in the hepatocytes
(Campion et al., 2008).
Blood  flow  generates  mechanical  effects  to  the  hepatocytes,  and  its
unidirectional  drainage  between  portal  and  central  veins  results  in  local
concentration gradients of oxygen, nutrients, and growth factors. These
gradients  regulate  the  spatial  expression  of  genes  that  encode  for  drug
metabolizing enzymes, thereby establishing zones with different metabolic
activities (Fig. 3). Most drug metabolizing enzymes are preferentially
expressed in perivenous hepatocytes with the lowest oxygen levels (Godoy et
al., 2013).
Also, the liver´s ECM plays a pivotal role in determining the phenotype of
hepatocytes  even  though  it  occupies  only  a  small  fraction  of  the  total  liver
volume (Kleinman et al., 1986; Dutta and Dutta, 2009; Bowers et al., 2010).
The composition of the ECM is zonally distributed in the liver and follows the
oxygen gradient between the portal vein and the central vein (McClelland et
al.,  2008).  Type  I  collagen,  type  III  collagen,  hyaluronan,  and  laminins  are
most  prominent  near  the  portal  vessels,  whereas  type  IV  collagen,  type  VI
collagen, and fibronectin are in the central vein zones (Martinez-Hernandez,
1984; Martinez-Hernandez and Amenta,  1993; Pinkse et  al.,  2004) (Fig.  3).
The fibrous proteins, such as collagens, self-assemble and form nanofibrillar
networks (Kleinman et al., 1982; Fernandes et al., 2009) that offer structural
support to hepatocytes and guidance for cell attachment, growth, migration,
and differentiation. In contrast, proteoglycans such as heparan sulphate,
which  is  also  located  in  the  liver´s  ECM,  function  as  signaling  receptors
(Wells,  2007).  In  addition,  the  stiffness  of  the  ECM  has  been  reported  to
direct the differentiation and proliferation of hepatocytes (Wells, 2008;
Lozoya  et  al.,  2011).  If  the  stiffness  surpasses  the  typical  levels  in  the  liver
(approximately  1–2  kPa)  (Asbach  et  al.,  2008;  Chatelin  et  al.,  2011),  the
hepatocytes start to proliferate and dedifferentiate (Semler et al., 2000;
Fassett et al., 2006; Hansen et al., 2006), whereas on a soft surface, such as
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collagen  hydrogel  and  laminin-rich  basement  membrane  hydrogel,  the
hepatocytes remain differentiated and do not proliferate.
Figure 3 Diagram illustrating the microenvironmental factors that maintain the hepatic
phenotype in the liver. The phenotype and functions of the hepatocytes are
regulated by biochemical and mechanical signals from neighboring cells (e.g.
sinusoidal endothelial cells, Kupffer cells, and cholangiocytes), ECM (space of
disse), and blood flow. The local differences in these signals divide the functional
unit of the liver into distinct zones. The hepatocytes close to the hepatic portal vein
and the hepatic artery (zone 1) receive the blood richer in oxygen and nutrients than
those located near the central vein (zone 3), hereby inducing functionally different
hepatocytes into the zones. Hepatic stem cells and hepatoblasts locate in the zone
1, whereas metabolically active hepatocytes populate the zone 3. Also the non-
parenchymal cells and ECM are different between the zones. The figure bases on
the following publications (McClelland et al., 2008; Dash et al., 2012; Godoy et al.,
2013).
2.2 CURRENT IN VITRO LIVER MODELS FOR DRUG
DISCOVERY AND CHEMICAL TESTING
Laboratory animals are used as in vivo models to study drug metabolism and
toxicity. Nevertheless, interspecies differences in drug metabolism and
transport impair the clinical predictability of the animal experiments. The US
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FDA and the European Medicines Agency (EMA) have expressed
dissatisfaction  with  the  predictability  of  animals  and  encourages  the  use  of
alternative,  non-animal  tests  for  pre-clinical  safety  studies  (EMA,  1997;  US
FDA, 2004, 2006). These revelations have increased the interest and use of
in vitro models for drug and chemical testing (Table 1). Another motivation
for in vitro models is the growing ethical and economical pressure to reduce,
refine, and replace the use of animals. In 2011, the EU established a reference
laboratory for alternatives to animal testing (EURL ECVAM), with the aim of
validating the alternative methods for drug, chemical, and cosmetics testing.
Table 1 Current liver models for drug discovery and chemical testing: Advantages and
Disadvantages.
Model Advantages Disadvantages
Mice and rats
· in vivo · ethical concerns
· 3D cytoarchitecture · not HTS method
· functional drug metabolizing
enzymes, transporters and
bile canaliculi
§ not human drug
metabolizing enzymes and
transporters
Liver slices
§ in vivo microenvironment and
3D cytoarchitecture
§ short viability (24 h)
§ functional drug metabolizing
enzymes
§ limited nutrient and oxygen
diffusion to inner cell layers
§ transporters and bile
canaliculi
§ human liver slices are rather
difficult to get
§ not HTS method
Primary
hepatocytes
§ both phase I and II drug
metabolizing enzyme
activities at physiological level
§ difficult to maintain
§ not liver-like cellular
architecture
§ suitable for HTS
§ possible to screen for toxicity
§ limited growth activity and
life-span
§ rapid loss of drug
metabolizing enzymes and
transporters
§ large inter-individual
variation
§ limitedly available
Hepatic cell
lines
§ unlimited life-span
§ reproducible § many liver-specific functions
are lost or expressed at
non-physiological levels
§ not liver-like cellular
architecture
§ stable phenotype
§ some liver specific functions
§ suitable for HTS
§ easily available
§ some cell lines suitable for
long-term studies
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Stem cell
derived hepatic
cells
§ unlimited source of
hepatocyte-like cells
§ the quality of stem cells
varies
§ possible to establish cell
panels reflecting the variation
in population (with iPSCs)
§ heterogeneous populations
of liver-like cells
§ low yield of differentiated
cells
§ low levels of liver-specific
functions
§ no liver-like cellular
architecture
Liver
microsomes
§ part of the phase I and phase
II drug metabolizing enzymes
§ all CYP enzymes
§ transporters are absent or
not functional
§ lack of nuclear receptors
(prevents CYP induction
studies)
§ not suitable for toxicity
studies
§ interspecies differences with
animal-derived  microsomes
§ well characterized
§ easily available
§ suitable for HTS
Recombinant
drug
metabolizing
enzymes
§ suitable for single enzyme
studies HTS
§ not in vivo relevant
§ suitable for drugs eliminated
primarily by CYPs
§ no transporters
§ no toxicity studies
3D, three-dimensional; CYP, cytochrome P450; HTS, high throughput screening; iPSC,
induced pluripotent stem cell; UGT, uridine glucuronosyl transferase
2.2.1 LIVER SLICES
Human  liver  slices  are  a  model  for  metabolic  and  toxicity  studies  with  an
intact in vivo cellular microenvironment (Table 1). The cellular architecture
of the slices is similar with the intact tissue and the slices retain cell-cell and
cell-ECM  interactions  (Thohan  and  Rosen,  2002).  Liver  slices  with
thicknesses of 100–250 µm are optimal, enabling good drug permeation into
the inner layers of the slice (Olinga et al., 2001; de Graaf et al., 2006). Drug
metabolism, transport, and hepatotoxicity can only be studied for less than
24 hours due to the loss of  metabolizing activity in the slice (Elferink et  al.,
2011).  The  liver  slice  approach  is  also  limited  by  the  problems  of  slice
availability and low throughput of the method.
2.2.2 PRIMARY HEPATOCYTES
Primary human hepatocytes are considered the gold standard of in vitro liver
models in drug development (Thohan and Rosen, 2002; Wells, 2007). In the
late  1960s,  Berry  and  Friend  (1969)  harvested  viable  rat  hepatocytes  using
collagenase perfusion. Thereafter, primary hepatocytes have been studied
both  in  suspension  and  monolayer  cultures.  Human  hepatocyte  cultures
became  more  common  in  the  beginning  of  1980s  (Guguen-Guillouzo  et  al.,
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1982;  Guguen-Guillouzo  and  Guillouzo,  2010).  Later  developments  in
cryopreservation and commercial availability have contributed further to the
adaptation of primary hepatocytes for routine use.
However,  primary  hepatocytes  have  well-known  disadvantages,  such  as
limited availability of the liver tissue for cell harvesting, high functional
variability between hepatocytes from different donors, and difficulty
maintaining differentiated phenotype and functions in cell cultures. Primary
hepatocytes lose the liver-specific functions within a few days after their
isolation.  As  a  result,  a  range  of  methodological  improvements  has  been
tested to stabilize the hepatocyte phenotype in cultures. See the Section 2.3.
2.2.3 IMMORTAL LIVER CELL LINES
Hepatoma-derived cell lines, including HepG2, Hep3B, Huh7, and HepaRG,
are  potential  alternatives  to  human  hepatocytes  in  drug  metabolism  and
hepatotoxicity  studies  (Kanebratt  and  Andersson,  2008).  As  cell  lines,  the
hepatoma-derived cells may lack many features of the hepatocytes. However,
they have also obvious advantages: good availability, unlimited growth, easy
handling and absence of donor variability (Table 1). Moreover, the regulatory
agencies  accept  the  use  of  immortal  liver  cell  lines  for  drug  metabolism
studies  if  normal  induction  of  cytochrome  P450  (CYP)  enzymes  can  be
demonstrated (EMA, 2012; US FDA, 2012).
The  most  frequently  used  liver  cell  line,  HepG2,  was  derived  from  the
liver  tissue  of  a  male  patient  with  hepatocellular  carcinoma  (Aden  et  al.,
1979). This cell line has been shown to be equal to the primary hepatocyte in
assessing  parent  compound  toxicity  in  the  endpoint  assays  (Ekwall  et  al.,
1998; Noor et al., 2009; Mandenius et al., 2011), but it is important to note
that  HepG2  cells  could  not  metabolize  the  tested  drugs  (Noor  et  al.,  2009;
Gerets  et  al.,  2012),  showing  that  this  particular  cell  line  does  not  suite  the
study of metabolites, at least, when it is cultured conventionally on 2D plastic
or glass surfaces. Fortunately, improvements in the culture environment
have  shown to  induce  both  drug  metabolizing  enzymes  and  transporters  in
HepG2  cells  (Westerink  and  Schoonen,  2007;  Horiuchi  et  al.,  2009;
Nakamura et al., 2011; Oshikata et al., 2011).
A recent hepatoma cell line, HepaRG, was derived from a liver tumor of a
female patient who suffered from the hepatitis C virus and hepatocarcinoma
(Gripon et al., 2002). HepaRG is considered a superior cell line compared to
the other immortal hepatic cell lines. It expresses the metabolizing enzymes
at a level comparable to the primary human hepatocytes (Aninat et al., 2006;
Lubberstedt  et  al.,  2011).  In  addition,  HepaRG  cells  have  an  intact  nuclear
receptor pathways (pregnane X receptor [PXR] and constitutive androstane
receptor  [CAR]),  and  the  induction  of  CYP enzymes  is  comparable  with  the
primary  hepatocytes  (Kanebratt  and  Andersson,  2008).  This  cell  line  also
expresses several active drug transporters (Le Vee et al., 2006). The other
advantageous properties of HepaRG are the stability of the phenotype, which
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extends  to  several  weeks  in  duration  (Antherieu  et  al.,  2010),  and  its
suitability  for  toxicity  studies  (Le  Vee  et  al.,  2006;  Josse  et  al.,  2008;
Kanebratt  and  Andersson,  2008;  Antherieu  et  al.,  2010;  Lubberstedt  et  al.,
2011).  HepaRG  is  routinely  cultured  on  standard  2D  tissue  culture  plastics
with media containing a corticosteroid and insulin.
HepaRG  cells  are  commercially  available  (Life  Technologies)  as  a  fully
differentiated form that is suitable for drug metabolism studies, whereas the
original HepaRG hepatic progenitor cell line is a proprietary cell line that is
provided only to a few research laboratories. The versatile HepaRG
progenitor cell line expresses bipotent differentiation. At low density, the
HepaRG resembles liver progenitors, and in the confluent state, the culture is
composed of hepatocyte-like and cholangiocytes-like cells (Aninat et al.,
2006; Cerec et al., 2007). Furthermore, the differentiated cells show reverse
differentiation to the progenitor phenotype while seeded at low density. The
xenobiotic  metabolism  of  the  HepaRG  progenitor  is  initially  low,  but  is
induced after several weeks of treatment with dimethyl sulfoxide (DMSO)
(Aninat et al., 2006).
2.2.4 CELL-FREE METHODS
Liver microsomes are widely used in drug metabolism studies,  especially  in
CYP  metabolism  studies  (Table  1).  Microsomes  are  prepared  from  liver
homogenate and consist of the membranes of endoplasmic reticulum. Thus,
they  contain  phase  I  and  II  metabolizing  enzymes  that  are  bound  to  the
membranes (CYPs, uridine glucuronide transferases [UGTs], and flavin-
containing monooxygenases [FMOs]). Therefore, the “non-membrane
bound” phase II metabolism is missing (Björnsson et al., 2003). In addition,
microsomes host incomplete transport (uptake and efflux), and the existing
enzymes  (CYP  and  UGT  enzymes)  are  not  active  as  such,  but  require
“activation” or supplementation of co-substrates and/or co-enzymes (Jia and
Liu,  2007).  Microsomes  are  particularly  favorable  in  industrial  drug
discovery,  because  they  are  amenable  to  high  throughput  studies  (HTS);  in
addition,  they  are  economical  and  convenient  to  use.  The  results  from
microsomes  are  used  to  predict  intrinsic  hepatic  drug  clearance  in  humans
(Jia and Liu, 2007).
Recombinant  drug  metabolizing  enzymes  (e.g.,  CYPs  and  UGTs)  have
been  exploited  as  an  alternative  to  microsomes  in  drug  metabolism studies
(Table  1),  but  the  data  derived  from  recombinant  enzymes  is  generally  not
clinically relevant (Stringer et al., 2009). So-called S9 subcellular fraction is
also  used  in  the  metabolism  studies  together  with  microsomes.  This  liver
fraction  consists  of  the  cytosols  and  microsomes,  thus  containing  phase  I
enzymes (CYPs and FMOs) and phase II enzymes (glutathione S-transferases
[GSTs], sulfotransferases [SULTs], N-acetyltransferases [NATs], and UGTs).
S9 fraction, like microsomes, requires additional cofactors to maintain
metabolic activities. It is worth noting that utilization of the human liver S9
Review of the literature
24
fraction  is  diminished  by  the  interdonor  differences  in  drug  metabolizing
enzyme activities.
Drug transport (influx and efflux) can be investigated with cell membrane
vesicles. The membrane vesicles are isolated from the cells that overexpress a
transporter, and are, therefore, useful in determining when a transporter
transports a particular substrate.  Inside-out-oriented membrane vesicles are
used  to  study  efflux  transport  directly,  and  allow for  determining  transport
kinetic  parameters,  such  as  the  inhibition  constant.  Inside-out  vesicles  are
actually recommended in vitro models to study the function of efflux
transporters (Giacomini et al., 2010; Hillgren et al., 2013). However, the
membrane vesicles are not complete liver models, and do not allow in vitro
to in vivo extrapolation, because the role of a transporter in the presence of
other competing transporters remains unclear.
2.2.5 HEPATOCYTE-LIKE CELLS DERIVED FROM PLURIPOTENT
CELLS
During the last few years, pluripotent stem cells have been actively
investigated as a possible cell sources for drug testing due to their high self-
renewing capability and potential to differentiate into a wide variety of
somatic  cell  types,  including  hepatocytes  (Snykers  et  al.,  2009;  Guguen-
Guillouzo  and  Guillouzo,  2010).  Recently,  several  research  groups  have
demonstrated that embryonic stem cells or induced pluripotent stem cells
(iPSCs) can be differentiated in mature hepatocyte-like cells that express
liver-specific functions, including drug metabolism and drug transport (Duan
et  al.,  2007;  Si-Tayeb  et  al.,  2010;  Chen  et  al.,  2012;  Hannan  et  al.,  2013;
Shan et al., 2013), but quantitative and systematic evidence of success is still
missing.
The inefficient differentiation protocols, the low yield of metabolically
competent hepatocyte-like cells, and high costs are still major challenges and
prevent the use of stem cell-derived hepatocytes as alternatives to primary
hepatocytes. Future experiments will determine the role of pluripotent cells
as platforms for drug discovery.
2.3 METHODS TO IMPROVE LIVER CELL CULTURES
The  dissatisfaction  with  current  liver  cell  models  has  promoted  the
development of numerous new cell culture techniques (Fig. 4). The new
techniques are designed to retain hepatocyte phenotype and functions by re-
establishing physiological microenvironment stimuli (Fig. 3). The following
paragraphs introduce the most widely adopted technologies.
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2.3.1 CULTURE MEDIUM MODIFICATIONS
The simplest approach to improve liver cell cultures is to modify the culture
medium. In the 1970s, Williams et al. developed a culture medium to support
the growth in long-term cultures of adult liver epithelial cells (Williams and
Gunn,  1974;  Laishes  and  Williams,  1976).  Later,  the  culture  media  was
supplemented  with  cytokines  and  other  chemicals.  Improved  stability  was
achieved  using  additives,  such  as  DMSO  and  insulin  or  glucocorticoid
supplements  (Isom  et  al.,  1985;  Dich  et  al.,  1988).  To  optimize  culture
conditions  further,  the  effect  of  medium  components  to  the  drug
metabolizing enzymes and hepatobiliary transporters have been investigated
in more detail (Dich et al., 1988; Turncliff et al., 2006).
Figure 4 The cell culture techniques for liver cells to retain hepatocyte phenotype and
functions. The chart was drawn upon the number of references available for the
search terms “liver cell culture medium modification”, “liver cell culture scaffold OR
liver cell culture sandwich OR liver cell culture hydrogel OR liver cell culture printed
surface OR liver cell culture micropatterned surface”, “liver cell co-culture”, “3D liver
cell culture OR three-dimensional liver cell culture OR spheroid liver cell culture OR
hanging drop liver cell culture”, and “liver cell culture perfusion OR liver cell culture
bioreactor” in the Scopus database (24.10.2013).
2.3.2 CULTURE MATRIX MODIFICATIONS
Another relatively simple approach to maintain hepatocyte functions is to
modify the culturing matrix. The matrix manipulation offers the cues missing
in  tissue  culture  plastic  and  may  allow anchorage  of  cells,  thus  guiding  the
functions  of  the  intracellular  biochemical  pathways.  Culturing  on  a  layer  of
type I collagen gel was invented in the 1970s (Michalopoulos and Pitot, 1975),
and  is  still  widely  used  for  primary  hepatocyte  culture.  A  collagen  gel  has
proven to support metabolism and transport activity of primary hepatocytes
for 72 hours (Rippin et al., 2001; Ulvestad et al., 2011).
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The cell growth environment has been further improved by culturing the
liver  cells  between  two  collagen  gel  layers.  The  sandwich  configuration
supports the viability, polarity, and hepatocyte functions better than a layer
of  collagen  gel  (Dunn  et  al.,  1991).  The  sandwich  culture  has  resulted  in
extended CYP activity, in vivo-  like distribution of  actin filaments (Dunn et
al., 1991), formation of canalicular network (LeCluyse et al., 1994), and
recurrence of both basolateral and hepatobiliary transporter activity
(Turncliff  et  al.,  2006;  Swift  et  al.,  2010).  The  sandwich  approach  has
enabled prediction of in vivo biliary  clearance  of  some  drugs  (Liu  et  al.,
1999).  In  addition,  Schaefer  et  al.  showed  that  protein  expression  levels  of
influx and efflux transporters in a human primary hepatocyte sandwich were
comparable to human liver tissue (Schaefer et al., 2012).
Also, other matrix modifications have been tested for the hepatocytes. See
Section 2.4.
2.3.3 CO-CULTURING WITH NON-PARENCHYMAL CELLS
Co-culturing of hepatocytes with non-parenchymal cells has been performed
for 30 years (Guguen-Guillouzo et al., 1983; Mesnil et al., 1987). It is known
that co-cultures of different cell types enhance the phenotype and functions
of  hepatocytes  (Guguen-Guillouzo  et  al.,  1983;  Harimoto  et  al.,  2002;
Takayama et al., 2007; Khetani and Bhatia, 2008). Thus, hepatocyte
phenotypic  functions  can  be  maintained  for  several  weeks.  The  effect  is
explained by direct heterotypic cell-cell contacts, and partially due to the
paracrine influences of cytokines secreted by the surrounding cells (Krause et
al., 2009). Co-culture with fibroblasts, hepatic stellate cells, Kupffer cells, or
liver sinusoidal endothelial cells have improved at least some of the hepatic
functions (Riccalton-Banks et al., 2003; Zinchenko et al., 2006; Khetani and
Bhatia, 2008; Krause et al., 2009).
Another motivation for co-culturing is that hepatotoxicity mechanisms
may require collaboration between different cell types of the liver. Thus, to
predict liver toxicity from in vitro data, hepatocytes have been co-cultured
with  immune  system  cells,  such  as  Kupffer  cells.  This  kind  of  co-culture
seems promising since it enhances cytotoxicity to the hepatotoxic chemicals
(Zinchenko et al., 2006; Edling et al., 2009).
There are several experimental approaches to perform co-culturing. This
includes  direct  co-culturing  on  standard  tissue  culture  plastic  (West  et  al.,
1985),  co-culturing  with  biomaterials,  where  hepatocytes  and  non-
parenchymal  cells  are  separated  typically  by  a  collagen  layer  (Bader  et  al.,
1996),  or  culturing  in  membrane  inserts,  where  different  cell  types  are
separated  by  a  membrane,  but  soluble  mediators  can  migrate  between  the
compartments  (Kang  et  al.,  2013).  Additionally,  co-culturing  has  been
performed on biodegradable surfaces (Riccalton-Banks et al., 2003), with cell
sheet technology where confluent cell monolayers of hepatocytes and non-
parenchymal cells are stacked on top of each other (Ohashi et al., 2007), and
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with 3D techniques where hepatocytes are co-cultured with non-
parenchymal  cells  using  a  hanging  drop  technique  to  form  heterotypic
spheroids (Messner et al., 2013).
2.3.4 THREE-DIMENSIONAL CULTURE TECHNIQUES
While hepatocytes have a 3D polygonal shape in the body, they present
flattened  morphology  on  the  standard  2D  cultures,  where  half  of  the  cell
surface  is  exposed  to  the  growth  media  fluid  and  the  other  half  to  the  stiff
surface. The flattened cell morphology limits cell-cell interactions, and
consequently  leads  to  reduced  polarization,  loss  of  important  signaling
pathways, and, thus, reduced liver functions. Therefore, researchers have
been interested in retaining the physiological cell-cell and cell-ECM contacts
by various 3D cell-culture techniques.
Cellular  spheroids  are  simple  3D  systems,  which  take  advantage  of  the
natural  tendency  of  many  cell  types  to  aggregate.  Spherical  multicellular
aggregates, spheroids, are formed when the cells self-assemble and re-
establish  the  cell-cell  contacts  in  three  dimensions.  Formation  of  3D
spheroids  was  first  reported  by  using  non-adherent  plastic  (Landry  et  al.,
1985). Since then, spheroids have been generated by different methods, such
as  culturing  on  non-adherent  materials  (Timmins  et  al.,  2005),  agitation/
rotating  vessels  (Li  et  al.,  1992;  Surapaneni  et  al.,  1997),  hanging  drops
(Timmins et  al.,  2005; Müeller  et  al.,  2011),  and gel  entrapment (Semino et
al., 2003). All these techniques regulate the extracellular environment of the
cell culture.
Many spheroid cultures of  liver cells  show prolonged survival  (Landry et
al., 1985; Tostoes et al., 2012), in vivo-like morphological characteristics,
such  as  polarity  (Müeller  et  al.,  2011;  Oshikata  et  al.,  2011;  Tostoes  et  al.,
2012),  enhanced secretion of  albumin and urea,  and formation of  bile  acids
(Walker and Woodrooffe,  2001;  Yang et  al.,  2002).  The beneficial  effects  of
spheroid  culture  are  believed  to  result  from  the  retention  of  the  3D
cytoarchitecture, an increased number of cell-cell contacts and the possible
presence of ECM components (Landry et al., 1985; Luebke-Wheeler et al.,
2009; Sakai et al., 2010).
Although  the  spheroid  technique  has  been  applied  for  years,  its  use  in
drug  and  chemical  testing  is  in  its  early  stages,  and  only  a  few  research
groups  have  aimed  to  develop  liver  spheroids  for  drug  toxicity,  efficacy,  or
metabolism  testing  (Müeller  et  al.,  2011;  Fey  and  Wrzesinski,  2012).  The
other challenge needing further evaluation is the use of human liver cells
because researchers are mainly using animal cells to generate spheroids.
Various matrices, scaffolds, bioreactors, and microfluidic platforms can
support 3D cell growth and improve liver-specific behavior and morphology.
More on these systems is discussed in the following paragraphs.
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2.3.5 BIOREACTOR AND PERFUSION TECHNIQUES
Generally, liver cell cultures are static. To mimic blood and fluid circulation
in the liver tissue, methods where cell culture fluids are in motion have been
developed. The well-known example of perfused liver models is the liver
slices. Recently, 3D cultures have been combined with perfusion or
bioreactor  systems  with  the  aim  of  overcoming  possible  nutrient  transport
limitations.  Cells  can  be  cultured  either  as  aggregates,  such  as  spheroids  in
stirred bioreactors, or assembled on the surfaces of a compartmental
bioreactor (Mandenius et al., 2011). To further improve the culturing
environment, cells can be encapsulated in a hydrogel or microcarrier before
populating  in  a  stirred  bioreactor;  alternatively,  the  bioreactor  can  be
surfaced with microstructures (Miranda et al., 2010).
Bioreactors have been shown to support  3D architecture of  the cells  and
to improve hepatocyte-specific functions of liver cells (Miranda et al., 2009;
Darnell et al., 2011). The reasons for improved phenotype could be that fluid
flow mimics the physiological gradients, allows control of oxygen, and assists
the  nutrient  and  waste  product  exchange.  Additionally,  dynamic  cultures
generally improve the formation of cell-cell contacts. However, the shear
stress alone cannot maintain the phenotype of hepatocytes, but it can affect
the cells  too strongly,  above the levels  of  physiological  hydrodynamics (Roy
et  al.,  2001).  The  hepatocytes,  which  are  in  direct  contact  with  the  fluid
motion, are gradually damaged by shear stress, suffer from a short lifespan,
and are thereby only appropriate for short-term studies (Kim et al., 1998;
Cervenkova et al., 2001).
When  Park  et  al.  (2008)  compared  the  effect  of  shear  flow  on  the
hepatocytes in the scaffolds of different pore sizes, they noticed that the cells,
which were better protected from the shear stress, expressed higher viability
than those exposed to a higher shear force. The studies where hepatocytes
are protected from direct contact, for example gel entrapment, have given
promising  results  (Tostoes  et  al.,  2012;  Dash  et  al.,  2013).  Tostoes  et  al.
(2012)  showed  that  a  bioreactor  can  maintain  CYP  enzyme  expression  and
biotransformation of xenobiotics for a longer duration than the
corresponding plated 2D cells.
2.4 BIOMATERIALS AS A PART OF THE LIVER CELL
CULTURE
As  early  as  the  1950s  it  was  realized  that  traditional  culturing  on  the  rigid
polystyrene or glass surface might not serve its purpose (Leighton, 1951). The
importance of the cell culture matrix for the formation of hepatocyte polarity
and directional functions has been known since the 1980s (Chambard et al.,
1981; Chen et al., 1985; Dich et al., 1988). Thereafter, several articles have
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testified that ECM resembling biomaterials are suitable for liver cell culturing
(Fig. 5).
Generally,  biomaterials  are  used  as  surrogates  of  the  missing
physiological ECM. The biomaterial must be biocompatible, provide support,
and  allow  for  cell  growth.  At  its  best,  the  biomaterial  represents  the
geometry,  chemistry,  and  signaling  environment  of  a  natural  ECM.
Furthermore, an optimal biomaterial would support cell adhesion,
proliferation, differentiation, and ECM production. Since hepatocytes are
known to be anchorage dependent (Underhill et al., 2007b), adhesion ligands
on the biomaterial might facilitate the cell culture.
A  completely  different  approach  to  support  a  liver  cell  culture  with
biomaterials  is  to  use  non-adherent  materials  to  minimize  the  cell-ECM
contacts  and  hereby  support  the  cell-cell  contacts  (Landry  et  al.,  1985;
Timmins et al., 2005). These kinds of biomaterials do not particularly mimic
the physiological ECM, but must be biocompatible and allow for cell growth.
Figure 5 Biomaterials are widely used for liver cell culturing. Synthetic polymer scaffolds are
the most typical biomaterials, whereas acellular liver matrix, which is obtained by
decellularization of the liver tissue, is not so common, but has attracted interest
lately. The chart was drawn upon the number of references available for the search
terms “liver cell culture scaffold, “liver cell culture hydrogel”, “liver cell culture printed
surface OR liver cell culture micropatterned surface”, and “liver cell culture acellular
matrix OR liver cell culture decellularized matrix” in the PubMed, Web of Science,
and Scopus databases, and Google scholar (14.4.2014).
2.4.1 PREFABRICATED POLYMER SCAFFOLDS
Biomaterial scaffolds have been produced as synthetic ECM to enable the 3D
organization  of  liver  cells.  Scaffolds  are  designed  to  be  porous  and  their
mechanical properties should be viscoelastic like natural tissue. In practice,
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and printed
surfaces
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the cells are seeded in prefabricated scaffolds where they grow on the surface
of  the  pores  and  may  form  3D  cell  assemblies.  Especially,  biodegradable
scaffolds have been widely investigated since they may be further suitable for
tissue engineering purposes (Griffith et al., 1997).
The most successful synthetic polymers include poly(lactic acid) (PLA),
poly(glycolic acid) (PGA), and poly(lactic-co-glycolic acid) (PLGA). The PLA,
PGA,  and  their  derivatives  have  supported  3D  hepatocyte  growth  for  up  to
two weeks (Hasirci et al., 2001). More recently, a cross-linked polystyrene
scaffold, AlvetexTM (Reinnervate),  has  been  shown  to  support  hepatocyte
morphology and upregulation of CYP enzymes better than the conventional
2D polystyrene plasticware (Schutte et al., 2011; Burkard et al., 2012).
The  scaffold  based  on  the  natural  alginate  polymer,  AlgiMatrix
(Invitrogen),  has  shown to  increase  the  aggregation  of  primary  hepatocytes
(Glicklis et al., 2000), to maintain albumin synthesis of primary hepatocytes
(Rowley  et  al.,  1999;  Glicklis  et  al.,  2000),  and  to  increase  CYP  and  UGT
enzyme activity of C3A hepatocyte cells (Elkayam et al., 2006).
A disadvantage of prefabricated polymer scaffolds is that they have
micrometer-based openings that generally induce flat 2D geometries of the
cultured cells and limit the number of cell-cell contacts. The other drawback
of synthetic scaffolds is that they are rather rigid, and do not allow the cells to
remodel  and  adapt  their  microenvironment  as  they  do  in  the in vivo.
Prefabricated scaffolds may have more potential for tissue engineering
applications than for the in vitro cell  models.  In  fact,  the  scaffolds  have
proven to be ideal in tissue engineering of bone and cartilage.
2.4.2 MICROPATTERNED AND PRINTED SURFACES
The most recent approach to apply biomaterials in hepatocyte culturing is to
use  lithography  or  printing  technologies  to  generate  patterns  and  surfaces
that  mimic  the  geometry  of  natural  ECM.  Microscale  surfaces  resemble
natural dimensions and offer control over cell-ECM and cell-cell interactions
with micrometer precision. Biomolecules, such as collagen I, have been
patterned  on  glass  or  polystyrene  substrates  (Khetani  and  Bhatia,  2008;
Ukairo  et  al.,  2013),  generating  patterns  that  are  perfectly  suited  for  co-
culturing because of the control on the proximity of one cell type to another
(Zinchenko et al., 2006; Wang et al., 2010; Ukairo et al., 2013).
The other main advantage of micropatterned and printed surfaces is that
they  can  be  produced  and  utilized  in  the  HTS  format.  Microscale  cultures
would be especially useful for drug discovery because both the amount of the
drug candidate and the cells are limited, and screening is highly appreciated.
Recently, Hepregen Corporation started to market patterned hepatocyte
cultures (HepatoPacTM)  for  metabolism  and  toxicity  studies  (Chan  et  al.,
2013; Ukairo et al., 2013). It has been reported that these micropatterned
hepatocyte fibroblast co-cultures maintain liver-specific functions, including
phase  I  and  phase  II  metabolism  (CYP2A6,  CYP2B6,  CYP3A4,  some  UGTs
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and SULTs) and active efflux transport of 5-(and 6)-carboxy-2´,7´-
dichlorofluorescein diacetate for several weeks (Khetani and Bhatia, 2008;
Ukairo et al., 2013).
The  disadvantage  of  these  cultures  is  that  they  represent  more  of  a  2D
than a 3D environment, and thus do not support the natural 3D organization
of  hepatocytes.  In  addition,  the  localization  and  expression  of  drug
transporters  in  this  system  is  not  known,  or  at  least,  this  has  not  been
published.
2.4.3 DECELLULARIZED LIVER MATRICES (BIOMATRICES)
Hepatocytes have been successfully cultured on decellularized liver-derived
ECM since the 1980s (Rojkind et  al.,  1980; Enat et  al.,  1984).  However,  the
interest  to  use  a  fully  physiological  biomatrix  as  cell  culture  platform  has
arisen again.
A liver biomatrix is prepared by perfusion of the tissue with enzymes and
detergents to remove the cellular compartments, while preserving the
structural  features  and  biochemical  components  of  the  matrix  (at  least
collagen  type  I  and  IV,  fibronectin,  and  laminin  β1)  (Uygun  et  al.,  2010).
Generally, hepatocytes are introduced to a decellularized whole organ
construct.  These  kinds  of  whole  organ  constructs  have  shown  to  maintain
albumin and urea synthesis of primary hepatocytes up to five days, but have
not  been  able  to  maintain  the  expression  of  phase  I  and  II  metabolizing
enzymes (Uygun et al., 2010).
Lately, biomatrices have been processed further to produce biomatrix
hydrogel. Lyophilization, grinding, and dissolution of the decellularized liver
matrix have shown to produce a biomatrix hydrogel  suitable for 2D and 3D
cell cultures (Sellaro et al., 2010; Lee et al., 2014). The hydrogel maintained
the  cellular  viability,  albumin  secretion,  and  urea  synthesis  of  primary
hepatocytes (Lee et al., 2014). However, the effect of the biomatrix hydrogel
on drug metabolism or transport functions remains unknown.
The evident advantage of biomatrices is the preservation of liver-specific
ECM  and  3D  architecture,  providing  essential  signals  for  long-term
hepatocyte function. However, biomatrices are highly variable because of the
donor-donor variability.
2.4.4 BIOMATERIAL HYDROGELS
Hydrogels  have  demonstrated  great  potential  for  cell  culture  and  tissue
engineering applications (Drury and Mooney, 2003; Peppas et al., 2006;
Kopecek,  2007).  They  are  a  promising  class  of  biomaterials  consisting  of
cross-linked hydrophilic polymers. The cross-linked structure prevents
dissolution  in  water,  but  allows  water  penetration  between  the  polymer
chains, causing swelling and formation of the hydrogel. The porous structure
with high water content allows efficient transport of oxygen, nutrients, and
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drugs, and facilitates removal of waste molecules (Drury and Mooney, 2003),
making hydrogels appealing for cell culturing applications. The highly
swollen  and  soft  nature  of  hydrogels  resembles  the  tissue,  where  cells  are
capable of remodeling and adapting to their microenvironment according to
their developmental needs.
Furthermore, polymer networks resemble the physiological ECM
networks  of  collagen,  elastin,  and  proteoglycans,  and  they  can  be  self-
assembled from smaller counterparts (bottom-up) like physiological ECM
(Zhang  et  al.,  1995).  In  addition,  mechanical,  responsive  and  diffusive
properties  of  hydrogels  can  be  tailored  and  the  optimal  composition  and
crosslinking selected for each cell  type (Table 2).  The possibility  of  growing
the cells within or on top of the gel further widens their usefulness.
2.4.4.1 Mammalian natural hydrogels
Due  to  their  biocompatibility,  several  natural  hydrogels  have  been  used  in
liver cell cultures. Many natural hydrogels have been extracted from animals
or cultured cells (Table 2). Collagen is the main protein of mammalian ECM.
Collagen fibrils are composed of triple helixes of proteins that are capable of
forming hydrogels in in vivo and in vitro environments (Fig. 6). Based on the
structure  and  the  genes  used  for  their  assembly,  the  collagens  are  divided
into subtypes (e.g., I, III, IV, and VI types). Collagens are perhaps the most
commonly used hydrogels in the liver cell cultures (see Subsection 2.3.2).
Collagen solutions are cross-linked either chemically or physically, leading to
the formation of fibrillar networks resembling the physiological counterparts
(Table 2).
The commercially available laminin-, collagen IV-, and entactin-rich
mammalian ECM hydrogel, MatrigelTM,  is  cross-linked  and  forms  networks
due to the interaction of ECM components with each other. Interestingly, the
structure of the network depends on the underlying material. On polystyrene,
Matrigel forms globular networks, whereas on hydrophilic surfaces (glass),
the networks are fibrillar (Kohen et al., 2009). The variability is increased by
the  fact  that  Matrigel  contains  over  1,000 different  proteins  (Hansen  et  al.,
2009).  Matrigel  has  been  shown  to  maintain  the  differentiated  liver  gene
expression (Schuetz et al., 1988) and albumin secretion (Moghe et al., 1996),
and to increase CYP2C9, CYP2D6, and CYP3A4 metabolism and sensitivity to
hepatotoxic compounds (Ramaiahgari et al., 2014), but it has also generated
a non-physiological cell morphology (Moghe et al., 1996).
The advantage of mammalian-derived hydrogels, such as collagen,
hyaluronan (HA)  and  fibrin,  is  that  they  contain  the  cell-signaling  domains
that are present in in vivo ECM, and hence, may enable in vivo-like behavior
of  hepatocytes  (Fig.  6).  However,  mammalian-derived  materials  have  poor
mechanical  properties  and  are  subject  to  enzymatic  degradation  in  human
cell  culture  environments  (Lee  et  al.,  1995).  This  is  advantageous  in  most
tissue  engineering  applications,  but  it  makes  their  use  in  routine  cell
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culturing  difficult.  In  addition,  the  mammalian  hydrogels  suffer  inherent
variation of undefined components, creating significant batch-to-batch
variability (Prestwich, 2007; Serban and Prestwich, 2007). This may hamper
the reproducibility of the cell cultures. However, some ECM components,
such as laminins and fibronectin,  are available in pure format,  produced by
recombinant technique.
Figure 6 Chemical structures of the central hydrogel forming polymers. Collagen and
PuramatrixTM consist of amino acids sequences that self-assemble to fibers,
whereas hyaluronan and nanofibrillar cellulose (NFC) are polymers composed of
sugar units, and polyethylene glycol (PEG) is a polymer of ethylene oxide.
2.4.4.2 Non-mammalian natural hydrogels
Alginate and chitosan are frequently used hydrogels for hepatocyte culturing
(Underhill et al., 2007b) (Table 2). They are non-mammalian natural
polymers that can be chemical or physically cross-linked (Table 2). Alginate
is  derived  from  marine  algae  sources,  and  chitosan  from  shellfish  shells.
Alginate has been extensively studied for hepatocyte encapsulation in both
static and dynamic environments, because it is known to degrade slowly (Lee
et al., 1995).
Recently, interest has grown in applying NFC in tissue engineering. The
NFC consists of anhydrase glucose units building linear chains (Klemm et al.,
1998)  (Fig.  6),  that  finally  form  a  nanofibrillar  network  mimicking  the
architecture of natural fibrils in the ECM (Klemm et al., 2011). However, NFC
does  not  offer  biochemical  signals  that  are  found  in  the  human  ECM.  This
Review of the literature
34
disadvantage  is,  however,  linked  to  all  natural  non-mammalian  hydrogels,
and also to the widely applied alginate and chitosan.
NFC is  produced  by  both  top-down and  bottom-up processes.  The  plant
NFC is obtained when plant cellulose (top-down) is disintegrated using high
shear forces, whereas bacterial NFC (bottom-up) is obtained by biosynthesis
of  cellulose  by  bacteria  (Siro  and  Plackett,  2010).  The  bacterial  NFC  has
already proven to be suitable for the tissue engineering of hard tissues such
as  bone  and  cartilage  (Andersson  et  al.,  2010;  Klemm  et  al.,  2011),  but
recently, interest has arisen in applying plant-derived NFC in tissue
engineering. The main reasons for the growing interest in plant cellulose are
the need for defined materials in tissue engineering, and at the same time the
need for new applications for cellulose,  as  the traditional  use of  cellulose in
the paper industry wanes.
Plant  NFC  differs  considerably  from  bacterial  cellulose  scaffolds  by  its
mechanical properties. The significantly lower Young’s moduli of plant NFC
from that of bacterial nanocellulose (15 Gpa versus 79–134 Gpa) is the result
of  a  lower  degree  of  polymerization,  reduced  crystallinity,  and  a  lack  of
alignment (Klemm et al., 2006; Tanpichai et al., 2012). Thus, the plant NFC
could  suit  the  engineering  of  soft  tissues,  such  as  the  liver,  rather  than  the
hard tissues. Moreover, the stiffness of the plant NFC hydrogel can be tuned
simply  by  adjusting  the  concentration.  The  storage  moduli  (G´),  which
express the elastic character of the gel, has shown to range from 105 to 102 Pa
with the concentrations of 0.13 and 6 % (Pääkkö et al., 2007).
Thus  far,  plant  NFC  has  been  applied  as  a  reinforcing  agent  in  diverse
composites  aiming  for  tissue  engineering  applications  (Borges  et  al.,  2011;
Cherian  et  al.,  2011;  Eyholzer  et  al.,  2011;  Mathew et  al.,  2012a;  Mathew et
al.,  2012b).  However,  to  the  best  of  our  best  knowledge,  plant-derived  NFC
has not been studied as a cell-supportive matrix as such. To clarify, the wood-
derived NFC was applied in this thesis to determine its suitability in cell
cultures (I, III).
2.4.4.3 Synthetic hydrogels
Synthetic hydrogels represent attractive alternatives to naturally derived
substrates, since they have a more defined structure, properties, and
improved reproducibility. Poly(ethylene glycol) (PEG) and its derivatives are
among the most widely studied hydrogels for biomedical applications (Table
2). Native PEG is a passive cell culturing material (Peppas et al., 2006; Zhu,
2010),  but various modifications of  PEG have been done to improve its  cell
adhesion  properties  (Hern  and  Hubbell,  1998).  The  pore  size  of  PEG
hydrogels  is  generally  smaller  than  that  of  biological  fibrin  and  collagen
networks that  can interfere with cell  proliferation and migration (Raeber et
al., 2005). Polyhydroxyethyl methacrylate (pHEMA), poly(vinylalcohol)
(PVA),  and  their  derivatives  are  also  widely  studied  synthetic  hydrogels  in
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biomedicine (Landry et al., 1985; Stol et al., 1993; Chirila, 2001; Schmedlen
et al., 2002).
Because synthetic ECM analogs often fail to recapitulate essential
biological  features  such  as  biological  recognition  (Goldberg  et  al.,  2007),
protein- and peptide-based synthetic polymeric materials have been
developed.  These  ECM  analogs  can  offer  cell  recognition  sites  originating
from their  biological  structure  even  though it  is  chemically  designed  (Table
2). For example, the repeating sequence (RADA) of a commercially available
PuramatrixTM hydrogel (BD Biosciences) mimics the well-known cell
adherence  motif  of  fibronectin  (RGD).  In  addition,  the  fiber  size  of
Puramatrix resembles the size of natural ECM fibrils (Zhang et al., 1995). The
Puramatrix nanofibrillar network self-assembles when salts are introduced
(e.g.,  culture  media)  in  the  bottom-up  way,  thereby  mirroring  the  natural
ECM  (Fig.  6).  Puramatrix  has  also  shown  to  maintain  differentiated
functions  of  porcine  hepatocytes  (Navarro-Alvarez  et  al.,  2006)  and  rat
hepatocytes (Wang et al., 2008). In addition, it has promoted differentiation
of rat liver progenitors into hepatocyte-like cells, shown by upregulated CYP
activity  and  albumin  secretion  (Semino  et  al.,  2003).  This  thesis  evaluated
the suitability of Puramatrix hydrogel for human liver cells (I, II).
2.4.4.4 Composite hydrogels
To  overcome  the  drawbacks  of  natural  and  synthetic  materials,  semi-
synthetic hydrogels have been developed that encompass the positive
features  of  both  natural  and  synthetic  hydrogels.  For  example,  HystemTM
(former name ExtracelTM hydrogel) (Glycosan Biosystems) is composed of
chemically modified gelatin (carboxymethyl gelatin-thiopropanoyl
hydrazide) and chemically modified hyaluronan (carboxymethyl hyaluronan-
thiopropanoyl hydrazide), which are cross-linked with polyethylene glycol
diacrylate (PEGDA) (Prestwick 2007, 2008, Shu 2004, 2006). The suitability
with  liver  cells  has  been  demonstrated  by  extended  CYP enzyme activity  of
hepatocytes  (up  two  weeks)  (Prestwich  et  al.,  2007).  To  further  clarify  its
beneficial properties on liver cells, the gelatin-hyaluronan hydrogel
(ExtracelTM, HystemTM) was used in this thesis (I, III).
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Table 2 Properties of biomaterial hydrogels.
Biomaterial type Material Biochemical
cue
Physical
cue
Composition Gelification mechanism Character Reference
Self-assembling
synthetic
polymers
Peptides Y Y defined divalent cations self-assembled nanofibrillar
network offering cell
attachment motif, degradable
in humans
(Semino et al.,
2003; Genove
et al., 2009)
Peptide amphiphiles Y Y defined pH or temperature
change, divalent cations
self-assembled nanofibrillar
network, degradable in
humans
(Hartgerink et
al., 2002; Luo
and Tong,
2011)
Synthetic
polymers
Poly(ethylene
oxide),
Poly(ethylene
glycol) and
derivatives
N Y defined photoinitiator and UV
exposure
network of macromolecule
chains, not fibrillar, non-
degradable in humans, FDA
approved biomaterial
(Raeber et al.,
2005; Liu
Tsang et al.,
2007;
Underhill et al.,
2007a)
Poly(vinyl alcohol)
and derivatives
N Y defined repeated freeze-thawing,
chemical crosslinking
with aldehydes, γ-
irradiation
rigid scaffold, high mechanic
strength, non-degradable in
humans, FDA approved
biomaterial
(Lu et al.,
2011;
Fejerskov et
al., 2012)
Natural polymers Alginate N Y defined divalent cations or
chemical crosslinking
polysaccharide, relatively
rigid scaffold, the gel
structure depends on the
(Glicklis et al.,
2000; Lan et
al., 2010;
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cross-linking agent, non-
degradable in humans, FDA
approved biomaterial
Miranda et al.,
2010; Bierwolf
et al., 2012)
Chitosan N Y defined pH or temperature
change, UV irradiation, or
chemical crosslinking
polysaccharide, degradable
in humans (enzymes mainly
lysozyme)
(Verma et al.,
2007; Feng et
al., 2009; Kim
and
Rajagopalan,
2010)
Nanofibrillar
cellulose
N Y defined colloidal dispersion, no
gelification
polysaccharide, nanofibrillar
entangled networks, non-
degradable in humans
(Klemm et al.,
2011)
Silk fibroin Y Y defined pH or temperature
change, divalent cations
protein, fibrous, high
mechanic strength, non-
degradable in humans (or
very slowly by enzymes),
FDA approved biomaterial
(Vepari and
Kaplan, 2007;
She et al.,
2008; Yang et
al., 2012)
Fibrin Y Y defined self-assembles when
fibrinogen reacts with
thrombin
protein, fibrillar network, low
mechanical strength,
degradable in humans,
contain arginine-glycine-
aspartic acid (RGD) sites
(Hokugo et al.,
2006; Ahearne
and Kelly,
2013)
Hyaluronan
(Hyaluronic acid)
Y Y defined chemical crosslinking ribbon-like entangled
network, polysaccharide,
hydrophilic, polyanionic
surfaces, degradable in
humans, FDA approved
(Lozoya et al.,
2011;
Prestwich,
2011)
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biomaterial
Laminin-111 Y Y  defined temperature change web-like fibrillar network,
generally combined with
other hydrogel component,
degradable in humans
(Bissell et al.,
1987;
Yurchenco et
al., 1992;
Pinkse et al.,
2004)
Fibronectin  Y  N  defined chemical or physical
crosslinking
not fibrous, generally
combined with other
hydrogel component,
degradable in humans
(Pinkse et al.,
2004)
Gelatin (soluble
derivative of type I
collagen)
Y Y nondefined chemical or physical
crosslinking or mixing
with other polymer
not fibrous structure, partially
hydrolysed collagen product,
degradable in humans
(Yang et al.,
2012)
Type I and IV
collagens
Y Y defined chemical or physical
crosslinking or mixing
with other polymer
fibrillar network, degradable
in humans
(Pinkse et al.,
2004)
Extracts from
animals/cells
Animal ECM
components
Y Y poorly defined temperature change globular or fibrillar network
depending on the surface
substrate, may contain also
growth factors, degradable in
humans
 (Kleinman
and Martin,
2005; Lee et
al., 2014;
Ramaiahgari
et al., 2014)
Human ECM
components
Y Y poorly defined temperature change degradable in humans (Maas-
Szabowski et
al., 2005)
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3 AIMS OF THE STUDY
The general  aim of  this  thesis  was to develop new organotypic in vitro liver
cell  culture  platforms.  The  study  aimed  to  clarify  the  potential  use  of
biomaterial hydrogels in the development of 3D liver cell cultures. Especially,
the effects of a 3D hydrogel culture on cytoarchitecture, drug metabolism and
excretion, and cellular differentiation were examined. The specific aims of
the study were:
1) To study the suitability of wood-derived NFC in a 3D cell culture (I).
2) To construct 3D liver cell cultures with HepG2 and HepaRG cell lines
and biomaterial hydrogels of peptide nanofibers, cellulose nanofibers,
hyaluronan-gelatin (HG) composite or natural ECM extract (I-III).
3) To  establish  analytical  methods  for  evaluation  of  3D  hepatocyte  cell
cultures  in  terms  of  cell  morphology,  polarity,  growth,  gene  and
protein expression and directional transport (I-III).
4) To investigate the effect of 3D hydrogel culturing on expression,
localization and function of selected drug metabolizing enzymes and
efflux transporters in HepG2 and HepaRG cell cultures (II, III).
5) To evaluate the impact of  biomaterial  hydrogels  on the phenotype of
both liver progenitor cells and differentiated hepatocytes by seeding
undifferentiated HepaRG cells and differentiated HepaRG cells to the
NFC and HG hydrogels (III)
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4 OVERVIEW OF THE MATERIALS AND
METHODS
The  effect  of  cell  culture  in  3D  hydrogels  on  cellular  organization  and
functions was investigated using HepG2 and HepaRG human liver cell lines
(II-III).  The  influence  of  several  hydrogels  (Table  3)  on  the  cellular
proliferation, viability, polarity (I-III), the membrane transporter proteins
(II-III),  and  also  on  the  cytosolic  metabolizing  enzymes  (III)  was
investigated.  Especially,  the  effect  of  biomaterial  hydrogels  on  the
expression, localization, and activity of the efflux transporters was explored
(II-III). In addition, the suitability of a novel NFC hydrogel in cell culturing
on the whole was studied (I). The experimental methods are summarized in
Table 4.  The materials  and methods are described in detail  in the following
sections.
Table 3 The biomaterial hydrogels in the publications I-III.
Biomaterial hydrogel Producer Character of hydrogel Publication
Nanofibrillar cellulose
(GrowdexTM)
UPM – The
Biofore Company
nanofibrillar network, colloidal
dispersion
I, III
Human basement
membrane extract
(MaxgelTM)
Sigma-Aldrich N.A. I
Hyaluronan-gelatin
(HystemTM, ExtracelTM)
Glycosan
Biosystems
fibrillar network I, III
Self-assembling
synthetic peptide
(PuramatrixTM)
3-D Matrix nanofibrillar network I, II
Self-assembling
synthetic peptide
(HydromatrixTM)
Sigma-Aldrich nanofibrillar network I
N.A., no answer
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Table 4 The experimental methods in the publications I-III.
Study objective Method Cell/Tissue type Gene/Protein/ Probe Publication
Morphology Phase-contrast microscopy HepG2, HepaRG - I-III
Staining of filamentous actin HepG2, HepaRG alexa594-phalloidin I-III
Viability and proliferation Mitochondrial activity HepG2, HepaRG Resazurin I-III
Live cell imaging HepG2 Fluorescein diacetate I
Live/Dead cytotoxicity assay HepaRG Calcein-AM/ Ethidium homodimer-1 III
Quantification of genomic DNA HepaRG PicoGreen III
Quantification of total protein HepG2, HepaRG Bicinchoninic acid I, III
mRNA expression Quantification of RNA HepG2, HepaRG, liver tissue absorbance at 260/280 II-III
Quality of RNA Human liver tissue electrophoretic analysis with RNA integrity
number algorithm
III
RT-qPCR with SYBR green HepG2, HepaRG, liver tissue ABCB1 II-III
HepaG2 ABCB11 II
HepG2, HepaRG, liver tissue ABCC2 II-III
HepaG2 ABCG2 II
HepaG2 SLCO1B1 and SLCO1B3 II
HepG2, HepaRG, liver tissue CYP3A4 II-III
HepaG2 CYP2D6 II
HepG2, HepaRG, liver tissue ALB II-III
HepaRG, liver tissue HNF4α III
HepaRG, liver tissue KRT19 III
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Protein expression ELISA HepG2, HepaRG ALB I
Protein localization Immunocytochemistry and
confocal microscopy
HepG2, HepaRG ABCB1 II-III
HepG2 ABCB11 II
HepG2, HepaRG ABCC2 II-III
HepG2 ABCG2 II
Functionality of MDR1 and
MRP2 canalicular efflux
transport
Efflux assay and confocal
microscopy
HepG2, HepaRG Fluorescein diacetate/ Fluorescein II-III
HepG2 Rhodamine123 II
HepaRG Calcein-AM/ Calcein III
CYP3A4 enzyme activity
and induction
Quantification of luminescent
compound
HepaRG Luciferin isopropyl acetate III
ABC, ATP-binding cassette; ALB; Albumin; AM, acetoxymethyl; CYP, cytochrome P450; ELISA, Enzyme-linked immunosorbent assay; HNF,
Hepatocyte nuclear factor; KRT19, Keratin 19; MDR1, Multidrug resistance protein 1; MRP2, Multidrug resistance-associated protein 2; PCR,
polymer chain reaction; SLCO, Solute carrier organic anion transporter; RT, real-time
Nanofibrillar cellulose hydrogel promotes three-dimensional liver cell culture
43
5 NANOFIBRILLAR CELLULOSE
HYDROGEL PROMOTES THREE-
DIMENSIONAL LIVER CELL CULTURE
Reprinted  with  permission  of  Elsevier  B.V.:  Bhattacharya  M,  Malinen  MM,
Lauren  P,  Lou  Y-R,  Kuisma  SW,  Kanninen  L,  Lille  M,  Corlu  A,  Guguen-
Guillouzo C, Ikkala O, Laukkanen A, Urtti A, and Yliperttula M. Nanofibrillar
cellulose hydrogel promotes three-dimensional liver cell culture. Journal of
Controlled Release 164: 291-298, 2012. Copyright 2012 Elsevier B.V.
http://dx.doi.org/10.1016/j.jconrel.2012.06.039
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6 PEPTIDE NANOFIBER HYDROGEL
INDUCES FORMATION OF BILE
CANALICULI STRUCTURES IN THREE-
DIMENSIONAL HEPATIC CELL CULTURE
Reprinted with permission of Mary Ann Liebert, Inc: Malinen MM,
Palokangas H, Yliperttula M and Urtti A. Peptide nanofiber hydrogel induces
formation of bile canaliculi structures in 3D hepatic cell culture. Tissue
Engineering Part A 18: 2418-2425, 2012. Copyright 2012 Mary Ann Liebert.
http://dx.doi.org/10.1089/ten.tea.2012.0046
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7 DIFFERENTIATION OF LIVER
PROGENITOR CELL LINE TO
FUNCTIONAL ORGANOTYPIC CULTURES
IN NANOFIBRILLAR CELLULOSE AND
HYALURONAN-GELATIN HYDROGELS
Reprinted with permission from of Elsevier B.V.: Malinen MM, Kanninen L,
Corlu A,  Isoniemi H, Lou YR, Yliperttula M, Urtti  A.  Differentiation of  liver
progenitor cell line to functional organotypic cultures in nanofibrillar
cellulose and hyaluronan-gelatin hydrogels. Biomaterials 35: 5110-5121,
2014. Copyright 2014 Elsevier B.V.
http://dx.doi.org/10.1016/j.biomaterials.2014.03.020
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8 SYNOPSIS OF THE MAIN RESULTS
The main results of this thesis are summarized in the Table 5.
Table 5 Summary of the main results in the publications I-III.
Characterization of nanofibrillar cellulose hydrogel Publication
Gel structure NFC hydrogel is based on nanofibers with average fiber diameter
of 20-30 nm resembling the natural ECM (e.g. fibrin fibers and the
smallest collagen fibrils).
I
Rheology Rheological measurements revealed that NFC hydrogel is a weak
gel with storage modulus (G’) of 10 Pa (0.5 % hydrogel). The
storage modulus (G’) is almost 10-fold higher than the loss moduli
(G’’) indicating a rather strong fiber network. The viscosity of the
hydrogel depends strongly on the NFC concentration. NFC
hydrogels show reversible gelation: it behaves as fluid under high
stress and solidifies at rest. The high resting viscosity (circa
20000 Pas for 1% hydrogel) may be useful in 3D cell culture.
I
Optical properties Lack of autofluorescence allows fluorescence imaging with low
background. NFC causes some light scattering.
I
Diffusion FITC-dextrans (mw range 20-250 kDa) had high diffusion
coefficients of 3x10-8-10-7 cm2/s in the NFC hydrogel (0.5 %
hydrogel) demonstrating that the hydrogels show only modest
resistance to the diffusion of macromolecules. Diffusibility
decreased with the increasing molecular weight.
I
Influence of 3D biomaterial hydrogel culture on the hepatic cells Publication
Cell proliferation The growth of HepG2 was slower in NFC and PM hydrogels
when compared to 2D environment. Similarly, the growth of
HepaRG was lower in NFC and HG hydrogels than in the 2D
cultures.
I-III
Cell viability NFC hydrogel did not show cytotoxicity at concentrations of 0.1-1
%. Viability of HepaRG and HepG2 cells in NFC and 2D cultures
was comparable.
   HepG2 aggregates were viable in PM hydrogel at least for
seven days.
   Viability of HepaRG aggregates in NFC and HG hydrogels was
maintained at least for two weeks. Mitochondrial activity of
HepaRG cells was lower in HG hydrogel than in the NFC
hydrogel and 2D cultures.
I-III
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Cell morphology,
shape
HepG2 and HepaRG formed multicellular aggregates in NFC,
HG, PM and HM hydrogels. HepG2 aggregates were regular and
spherical in NFC and PM hydrogels. The shape of HepaRG
aggregates was more diverse and included both regular spherical
aggregates and less organized aggregates, in PM, HG and NFC
gels.
   The shape of single HepG2 cells is flattened in 2D cultures but
in PM hydrogel HepG2 had polyhedral shape. HepaRG appears
in three different morphologies in 2D cultures: flat elongated
progenitor-like cells, granular hepatocyte-like cells and flattened
cholangiocyte-like cells, but in hydrogels HepaRG has cuboidal
shape.
I-III
Cell morphology,
Actin filaments
Stress fibers were seen on the interface of glass or plastic, but
not in the hydrogel cell cultures. Accumulation of actin filaments
on the apical side of HepG2 and HepaRG spheroids asserts the
in vivo-like apical-basal polarity and bile canaliculi formation.
I-III
Formation of bile
canaliculi
structures
HepG2 cells formed bile canaliculi in PM and NFC hydrogels. The
appearance of bile canaliculi structure was more evident in PM
hydrogel than in the 2D cultures. Instead no clear difference in
the bile canaliculi appearance between the NFC and 2D HepG2
cultures were observed. Localization of canalicular resident
transporters, MRP2 and MDR1, confirmed the formation of bile
canaliculi-like structures in PM hydrogel. MRP2 was correctly
localized also in the 2D HepG2 cultures.
   HepaRG liver progenitor cells formed bile canaliculi structures
both in NFC and HG hydrogels and 2D surfaces. Instead,
differentiated HepaRG cells formed bile canaliculi in 2D and HG,
but not in NFC. In 2D cultures, the canaliculi structures were
located in granular hepatocyte-like areas. MDR1 and MRP2 were
localized on the canalicular membrane of HepaRG progenitors in
NFC, HG and 2D. Also differentiated HepaRG cells expressed
MRP2 correctly in NFC, HG and 2D, but MDR1 was detected only
in 2D cultures.
I-III
mRNA
expression of
liver specific
markers
PM hydrogel did not change the albumin expression of HepG2.
The albumin expression increased over the culture time in all the
culture conditions of HepaRG progenitors and was higher in NFC
and HG hydrogels than in 2D cultures. On the contrary, albumin
expression was lower in NFC and HG hydrogels than in the 2D
cultures of differentiated HepaRG.
II, III
  The HNF4 expression was lower in NFC than in 2D and HG,
both in the cultures started with HepaRG progenitors and
differentiated HepaRG cells.
III
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   The KRT19 expression was low in the progenitor cultures in HG
hydrogel. In addition, KRT19 expression decreased over the time
in the NFC hydrogel and 2D cultures of progenitors. Differentiated
HepaRG cells expressed KRT19 more in NFC than in the EC and
2D. Overall the KRT19 expression was higher in HepaRG
compared to human liver.
III
mRNA
expression of
biotransformation
markers
PM hydrogel did not change the expression of CYP3A4,
CYP2D6, OATP1B1, OATP1B3, MDR1, BCRP, MRP2 or BSEP
in HepG2 cells.
   NFC and HG hydrogels increased CYP3A4 expression in
HepaRG progenitor cells. HG maintained the CYP3A4 expression
in differentiated HepaRG cells, but in NFC cultures the CYP
expression decreased.
II
 III
   HG increased both the MDR1 and MRP2 expression in
HepaRG progenitors. On the contrary, NFC and HG decreased
the MDR1 and MRP2 expression of differentiated HepaRG cells.
III
Albumin
secretion
HepG2 cells secreted albumin at similar level in NFC, PM, HM
and EC hydrogels. HepaRG cells increased albumin secretion
during the culture. The highest secretion was observed in three-
dimensional NFC and HG hydrogels.
I
CYP3A4 activity The CYP3A4 activity of HepaRG progenitors increased over the
time in NFC and HG hydrogels. Instead the activity of standard
2D HepaRG cultures remained at same level for the culture time.
Among HepaRG progenitor cultures the activity level was the
highest in NFC hydrogel.
   On the contrary, cultures started with differentiated HepaRG
showed higher CYP3A4 activity in 2D environment than in NFC
and HG hydrogels. In addition, the activity of NFC culture was
circa 100-fold higher than the corresponding EC cultures.
III
CYP3A4
induction
Rifampicin, phenobarbital and DMSO induced the CYP activity of
HepaRG cells in all tested culture environments. Instead
dexamethasone initiated induction was not observed.
III
Efflux
transporters
activity
Canalicular efflux transporters were active in PM cultured HepG2
spheroids shown by MRP2 and MDR1 substrates.
   Canalicular efflux transporters were active in all HepaRG
progenitor cultures including NFC, HG and 2D. On the contrary,
only a few spheroids in differentiated HepaRG cultures showed
active efflux. Canalicular efflux was more common in low-density
HepaRG spheroids than in the high-density ones.
II, III
3D, three-dimensional; ECM, extracellular matrix; FITC, fluorescein isothiocyanate; HG, hyaluronan-
gelatin; HM, HydromatrixTM peptide matrix; NFC, nanofibrillar cellulose; PM, peptide nanofiber
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9 GENERAL DISCUSSION AND FUTURE
PROSPECTS
9.1 TWO-DIMENSIONAL VERSUS THREE-
DIMENSIONAL LIVER CELL CULTURE
The current in vitro liver  models  are  generally  based  on  the  primary
hepatocytes that are cultured on polystyrene plastic as thin 2D monolayers.
These 2D cultures are suitable for routine analyses, and in high content
screening (HCS) and HTS procedures. However, 2D liver cell cultures poorly
mimic the conditions in the liver tissue,  and therefore,  are not good for the
prediction  of  drug  metabolism and  transport  in  the  human body  where  the
cells are interacting in a 3D environment.
As  the  need  for  predictive  liver  models  is  increasing,  especially  in  drug
transport and toxicity screening, there is strong demand for technologies that
enable fully functional liver cell cultures. The techniques that can create three
dimensions in the cell culture have especially evoked attention during the last
decade (Fig. 7).
Figure 7 The interest on 3D cell culture has emerged during the on-going decade while
biomaterial science and tissue engineering have evolved. The number of
publications was visualized based on the search performed with the terms
“Biomaterial”, “Tissue engineering”, and “3D cell culture OR 3-D cell culture OR
three-dimensional cell culture” in the PubMed database (24.10.2013). The search
was limited to in title/abstract fields.
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What makes 3D liver cell culture so interesting? Liver parenchymal cells,
hepatocytes, need to be highly polarized to be able to perform the vectorial
transport  from the  sinusoidal  domain  to  the  canalicular  domain;  therefore,
the hepatocytes could especially benefit from the multidimensional culture
environment that enhances the number of cell-cell contacts. Sandwich
configuration, which settles between the 2D and 3D culturing, has improved
both  the  architecture  and  the  functions  of  the  liver  cell  cultures.  However,
sandwich cultures have not been fully satisfactory due to the batch-to-batch
variability and poor availability of hepatocytes, as well as the limited lifetime.
Our studies together with earlier publications show that a true 3D culture
can  rebuild  the  hepatic  polarity  as  well  as  promote  drug  metabolism  and
transport (Dash et al., 2012; LeCluyse et al., 2012; Godoy et al., 2013) (I-III).
It is clear that 3D culture techniques can create more relevant in vitro
models compared with the conventional 2D technique. 3D minitissues with a
polarized architecture could offer improved models for the simultaneous
study of drug metabolism, vectorial transport, and toxicity. Currently, all
these properties must be studied with separate models: metabolism is
studied  with  microsomes  and  primary  hepatocytes,  vectorial  transport  with
inverted  vesicles,  cell  cultures  and  animals,  and  toxicity  with  animals  and
primary hepatocytes.
An important advantage of 3D cultures is that they can be formed from a
small number of cells, which is very beneficial when the cell source is limited,
such as stem cell-derived hepatocytes. Hence, a 3D culture may enable more
data points with a limited amount of  cells,  but then the smaller  culture can
also be a challenge because a more sensitive analysis technique is needed.
However, there is no validated 3D cell model. A few commercial 3D liver
cell  systems  exist  in  96-well  plate  format,  which  may  enable  HTS  of
metabolism or hepatotoxicity (Chan et al., 2013; Messner et al., 2013; Ukairo
et  al.,  2013).  All  of  these  systems  are  based  on  the  co-cultures  of  primary
hepatocytes with fibroblasts/non-parenchymal liver cells and have been
shown to maintain the CYP450 activity for 4–5 weeks, allowing for long-term
toxicity studies (Messner et al., 2013; Ukairo et al., 2013). These 3D formats
also  support  the  reconstruction  of  bile  canaliculi  structures.  However,  the
same  micropatterned  system  did  not  show  a  clear  advantage  over  the
hepatocyte suspension cultures when hepatic drug clearance was studied
(Chan et al., 2013). Before the 3D model can be widely used the model should
be  validated  and  characterized.  For  example,  the  quantitative  expression  of
drug  metabolizing  enzymes  and  transport  proteins  should  be  known  to  be
able to scale the in vitro data into in vivo.
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9.2 THE ROLE OF HYDROGELS IN THE DEVELOPMENT
OF ORGANOTYPIC LIVER CELL CULTURES
Soft biomaterial hydrogels have been exploited in cultures because the
conventional  glass  and  polystyrene  are  proposed  to  be  too  stiff  for
organotypic cell culturing. The hard surfaces favor a proliferative rather than
differentiated phenotype (Wells, 2008). Instead, hydrogels mimic the
stiffness of the tissue better than the conventional materials (Wichterle and
Lim,  1960),  and  can  offer  both  the  mechanophysical  and  biochemical  cues
towards  the  physiological  microenvironment  (Prestwich  et  al.,  2007).
Collagen hydrogel has played a remarkable role in the liver cultures since the
1970s  (Michalopoulos  and  Pitot,  1975).  Collagen  sandwich  conformation,
especially, has succeeded in remodeling liver cell cultures towards an
organotypic-style (Dunn et al., 1991), and function as the only in vitro model
for hepatobiliary transport (Brouwer et al., 2013). However, the sandwich
culture expresses a limited number of cell-cell contacts, rather low cell
density, a limited lifespan, and a dependency on primary hepatocytes;
therefore, improved true organotypic liver cell culture models are needed.
The good results achieved with collagens have encouraged the work with
hydrogels. The 3D cultures are formed by entrapping the cells in the hydrogel
or  by  culturing  the  cells  on  the  surface  of  non-adhesive  hydrogels.  The
advantages  of  hydrogel  entrapment  over  the  other  spheroid  forming
techniques (e.g., bioreactor, suspension, hanging drop) is that the cells are in
a soft environment, including fiber networks similar to the in vivo ECM. In
hydrogels, the cell receives both biochemical and physical signals of the ECM
and  is  not  forced  to  form  spheroids,  thereby  differing  from  the  other
spheroid techniques that force the cells to aggregate.
A  few  papers  show  that  the  3D  hydrogel  environment  can  induce  the
hepatocytes  to  form  cell  aggregates  with  a  polarized  architecture  and
extended/improved functions (Glicklis et al., 2000; Semino et al., 2003;
Prestwich et al., 2007; Ramaiahgari et al., 2014). Our 3D hydrogel cultures
with  HepaRG  cells  (I,  III)  are  the  first  ones  with  this  cell  line  and
demonstrate that the hydrogel technique suits the HepaRG culture as well as
the  3D  agitation,  hanging  drop,  and  bioreactor  approaches  (Darnell  et  al.,
2009; Darnell et al., 2011; Leite et al., 2012; Gunness et al., 2013). The study
with HepG2 (II) showed for the first time that this cell line benefits from the
RAD16-I peptide hydrogel.
Despite the potential advantages, the 3D hydrogel cultures are not the
most  popular  cell  culture  initiative  (Fig.  4).  The  reasons  might  be  that  it
requires experienced technique in the initiation and analysis of the cultures.
In  addition,  the  biomaterials  might  be  expensive  and  the  analysis  methods
must  be  modified  to  suit  hydrogel  cell  cultures.  Another  concern  is  the
variation in the spheroid size, and the restricted diffusion of nutrients,
oxygen,  and metabolites (such as bile  acids).  In addition,  stability  of  the gel
in long-term cultures is an issue. The challenges listed above must be solved
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before extensive application of hydrogel cell cultures in drug testing,
especially in HTS and HCS formats.
9.3 NANOFIBRILLAR CELLULOSE (NFC) HYDROGEL
AS A CELL CULTURING AGENT
Cellulose  draws  attention  because  it  is  the  most  abundant  polymer  in  the
world; thus, its availability is limitless. Plant-derived NFC started to receive
attention  in  the  beginning  of  the  twenty-first  century  when  it  could  be
produced  in  a  cost-effective  way  (Siro  and  Plackett,  2010).  To  date,  plant
NFC  has  been  utilized  as  a  reinforcement  agent  in  composites,  and  as  a
thickener or stabilizer in suspensions and emulsions (Klemm et al., 2011). In
addition,  a  few  studies  have  shown  its  potential  as  a  drug  delivery  system
(Kolakovic  et  al.,  2012a;  Kolakovic  et  al.,  2012b;  Valo  et  al.,  2013)  and  as  a
pharmaceutical excipient for tablet manufacturing (Kolakovic et al., 2011).
Recently,  interest  has  grown  in  applying  plant-derived  NFC  as  a
reinforcing  agent  for  tissue  engineering  composites  (Borges  et  al.,  2011;
Cherian  et  al.,  2011;  Eyholzer  et  al.,  2011;  Mathew et  al.,  2012a;  Mathew et
al.,  2012b).  However,  plant  NFC  hydrogel  has  never  been  studied  as  a  cell
culturing  matrix,  and  this  thesis  presents  the  first  publication  whereby  the
hydrogel of plant NFC is utilized as cell culturing material (I, III).
In  our  first  paper,  we  showed  that  the  fiber  network  and  rheological
properties of native NFC showed similarities to natural ECM (I). In addition,
the diffusion properties of macromolecules resembled the diffusion
coefficient in the natural ECM (I), and encouraged studying NFC hydrogel as
such  without  any  additives.  The  results  of  this  thesis  revealed  the
applicability of NFC in 3D cell culturing (I). Furthermore, the results showed
its capability to support morphological and functional differentiation of
HepaRG  liver  cells  (I,  III),  although  NFC  does  not  present  biological
adhesion  signals  that  might  be  necessary  for  cell  maintenance  and
differentiation. Hereby, the results of studies I and III confirm the recent
recognition that physical cues are important determinants of cell growth,
cellular  functions,  and  tissue  assembly  (Discher  et  al.,  2005;  Brandl  et  al.,
2007; Lozoya et al., 2011). Actually, it has been clearly demonstrated that
hepatocytes can survive in a 3D biomaterial environment without matrix-
based  biological  signals  as  long  as  the  environment  supports  3D  cell-cell
contacts.  These  kinds  of  materials  have  been:  PEG  hydrogels,  polystyrene
scaffolds, and pHEMA coated surfaces (Underhill et al., 2007a; Schutte et al.,
2011; Acikgöz et al., 2013).
The possibility of adding biological adhesion signals either by physical or
chemical binding, however, raises the usability of the NFC hydrogel. Simply
physical mixing of ECM proteins (e.g. collagen, laminin, or fibronectin) may
be  successful  because  the  NFC  hydrogel  slows  down  the  diffusion  of
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molecules  greater  than  70  kDa  in  size  (I,  Fig.  6A).  Thus,  even  though  the
ECM proteins are not covalently linked to the hydrogel, they may be retained.
If  covalent bonding of  biological  cues is  nevertheless desired,  the numerous
hydroxyl groups of NFC offer attractive targets for chemical modification
(Klemm  et  al.,  2011).  The  fact  that  NFC  resembles  the  already  successful
polysaccharide polymers, HA, alginate, and chitosan (Drury and Mooney,
2003), adds to the interest of the NFC hydrogel.
As an animal-free and fully characterized material, the NFC hydrogel does
not express batch-to-batch variability, thereby providing favorable
characteristics for tissue engineering and drug testing approaches. However,
mammalian cells are not capable of degrading the cellulose. This feature may
impede the utility of the NFC hydrogel in tissue engineering applications, but
the stability of the cellulose polymer may be actually preferential in in vitro
use enabling long-term cultures. The other advantageous characteristic of the
NFC hydrogel  is  the  transparency  that  allows  convenient  monitoring  of  cell
processes  by  traditional  optical  techniques  (I).  But  then,  NFC  hydrogel
filters, refracts, and scatters the light, thereby preventing the full depth
imaging of the culture and impairing the image quality. The light scattering,
refraction,  and  attenuation  are  typical  for  all  3D  hydrogels  (Tibbitt  and
Anseth, 2009).
NFC hydrogel is a preformed reversible colloidal gel; thus, no gelification
or use of toxic photoinitiators or crosslinking agents are needed. Instead, the
cells  are  mixed  into  the  hydrogel  (I).  This  is  possible  because  the  internal
structure of the hydrogel allows reversible “gelation”. The viscosity of the gel
decreases while shear stress, such as by regular pipetting, is introduced.
The preformed fibrillar network is also a challenge. When cell suspension
is  mixed  into  the  NFC  hydrogel  by  standard  pipetting,  the  heterogeneous
culture may be generated. The risk for heterogeneous culture increases while
the NFC concentration increases, meaning that the cell suspension is easier
to  mix  evenly  with  the  0.5%  hydrogel  than  with  the  1%  hydrogel.  The  cell
suspension,  as  well  as  the  growth  medium,  easily  forms  cavities  in  the
hydrogel, leading to uneven distribution of the cells and the gel (unpublished
data).  This  flocculation  phenomena  of  the  NFC  hydrogel  has  been
demonstrated with a combination of photography and rheological
measurements  (Karppinen  et  al.,  2012).  The  problem  relating  to  the
flocculation is that the uneven gel structure may promote the heterogeneous
cultures.
The  complete  mixture  of  cell  suspension  into  the  hydrogel  may  require
more  than  10  Pa  shear  stress  since  this  power  is  needed  to  decrease  the
viscosity  of  1%  NFC  hydrogel  (I).  In  fact,  the  manufacturer  (UPM-The
Biofore Company) recommends the use of a vortex mixer; however, this
produces too high of a speed for the living cells and is not an applied mixing
technique in the standard cell culturing.
The third major challenge of NFC hydrogel is that it tends to adhere to the
standard disposable polystyrene pipette tips, used in the cell culturing,
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probably  due  to  the  numerous  hydroxyl  groups  of  NFC.  In  addition,  NFC
hydrogel is a weak gel (I) in practice, meaning that it requires the support of
well  walls  to  maintain  the  cell  culture.  This  characteristic  may  prevent  the
wide applicability in HTS assays.
To  conclude,  NFC  hydrogel  has  several  positive  features  as  a  3D  cell
culture matrix. Therefore, it is a very good base material for the development
of physiologically relevant tissue models. For practical ease of use, some of its
properties still require optimization.
9.4 LIVER CELL MODELS AS PREDICTIVE TOOLS FOR
PHARMACOKINETICS AND TOXICITY IN HUMANS
Liver cell  models  are important in the early stages of  drug discovery due to
the central role the liver plays in drug metabolism, excretion, and toxicity
(EMA, 2008; Mandenius et al., 2011). Human pharmacokinetics and toxicity
are predicted using a combination of in vivo animal, in vitro human, and in
silico computational models. The current models are not anyhow satisfactory
and  they  are  primarily  designed  to  study  phase  I  drug  metabolism.  Some
pharmacokinetic  parameters,  such  as  the  inhibition  constant  for  drug-drug
interaction  (Ki),  can  be  obtained  with  primary  hepatocytes.  However,  the
high phenotypical variability and the underprediction of in vivo clearance,
limit the use of data from primary hepatocytes (Hallifax et al., 2010).
The study of vectorial transport has revealed its challenges (Giacomini et
al.,  2010;  US  FDA,  2011;  EMA,  2012;  Hillgren  et  al.,  2013).  Hepatic  influx
transporters can be studied using conventional hepatocyte cultures in
suspensions  or  monolayers,  but  the  study  of  hepatobiliary  efflux  transport
does  not  succeed  due  to  the  dislocation  of  the  transporters  in  the
conventional hepatocyte cultures (Hillgren et al., 2013). The efflux transport
is generally investigated with the membrane vesicles, which, however, have
shown  to  result  in  false  positives (Pedersen et al., 2013). Fortunately,
sandwich  cultured  hepatocytes  can  be  utilized  in  the  prediction  of in vivo
biliary  excretion  at  least  for  some  chemicals  (Abe  et  al.,  2009;  Swift  et  al.,
2010; Pedersen et al., 2013).
Primary  hepatocytes  or  hepatoma  cells  are  suitable  for  studying  the
hepatotoxic potential of the compounds. These models provide information
of toxicity mechanisms and can predict in vivo acute hepatotoxicity (Cheng et
al., 2011; Hrach et al., 2011). However, toxicity cannot be studied accurately,
because  the  conventional  2D  cell  models  are  altered  and  do  not  react  to
chemicals  with  the  same  sensitivity  as  the  liver  tissue  (Dash  et  al.,  2012;
LeCluyse et al., 2012). Long-term studies are also impossible due to the short
lifespan or unstable phenotype of the conventional 2D cultured cells.
This thesis together with other recent initiatives has proven that novel cell
culture techniques allow for the formation of 3D structures toward
organotypic tissue models (I-III) (Kim et al., 2012; Godoy et al., 2013). The
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improved architecture (II) and the functionality of liver cells (II, III) suggest
that  3D culture technology may provide a better  system for studies on drug
metabolism, vectorial transport, and toxicity. These kinds of organotypic cell
models have already been shown to allow the prediction of in vivo clearance
(Darnell et al., 2011), more accurate assessment of acute toxicity (Gunness et
al.,  2013),  and  long-term  toxicity  testing  with  repeated  dosing  (Messner  et
al., 2013).
In  the  future,  the  3D in vitro tissue models may become more
reproducible  and  predictive  test  systems  than  the  gold  standard  of  primary
hepatocytes.  Organotypic 3D models may replace or at  least  accompany the
current simplified drug screening models. At best, an organotypic 3D in vitro
liver  model  would  reduce  and  replace  the  use  of  laboratory  animals  and
improve  the  prediction  of  drug  effects  in  humans.  However,  there  is  still  a
long  way  to  go.  Before  its  wide  use,  the  3D  liver  models  should  be
standardized, validated, and approved by the regulatory authorities.
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10 SUMMARY AND CONCLUSIONS
This  thesis  introduces  new  3D  human  liver  cell  cultures  that  resemble  the
structures  and  functions  of  human  liver  tissue. The  main  conclusions  are
summarized in the following paragraphs:
1) The wood-derived NFC hydrogel was shown to suit the 3D cell culture.
The viscoelastic properties of NFC hydrogel allowed encapsulation of
cells into the preformed hydrogel and conventional gelification of the
hydrogel  initiators  was  not  needed.  NFC  hydrogels  were  compatible
with the cells, allowing for cell proliferation and aggregation.
2) The  hydrogels  of  NFC,  peptide  nanofibers,  and  HG  promoted  the
formation  of  3D  liver  cell  cultures.  Human  hepatoma  cells,  HepG2,
and  HepaRG,  organized  in  3D  aggregates  in  which  cells  expressed
polygonal morphology, differing from the flat and elongated
phenotype  of  the  2D  cultures,  and  thereby  representing  the in vivo
counterparts. This study shows for the first time that 3D culturing in
hydrogel  can  improve  the  polarity  of  HepG2  and  HepaRG  cells  (II,
III). The peptide nanofiber hydrogel improved the cytoarchitecture
and  liver-specific  functions  of  HepG2  cells  (I,  II),  whereas  NFC  and
HG hydrogels induced the properties of HepaRG cells (I, III).
3) Most  of  the  analytical  methods  were  modified  and  optimized  to  suit
3D cultures of hydrogels. Especially, the staining, viability analysis,
and the microscopy required revision to the standard protocols.
4) 3D hydrogel cultures were capable of remodeling the characteristics of
human hepatic cell lines, HepG2 and HepaRG. The spheroid structure
of HepG2 and HepaRG cells resembled the liver architecture, with
functional bile canaliculi-like structures and correct localization of
drug efflux transporters, MDR1 and MRP2. In addition, NFC hydrogel
promoted CYP3A4 metabolism and canalicular efflux transport of
HepaRG cells.
5) The  study  performed  with  HepaRG  liver  progenitors  and  HepaRG
hepatocyte-like cells revealed the importance of the differentiation
stage of hydrogel entrapped cells. NFC and HG hydrogels promoted
the differentiation of liver progenitor cells more than the standard 2D
culture environment. However, the hydrogels failed to maintain the
phenotype  of  differentiated  liver  cells  when  compared  to  the  2D
culture.
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Taken together, these results deepen our current knowledge of 3D liver
model development. Particularly, we compared the effect of different
hydrogels  to  each  other,  which  is  generally  not  done,  and  showed  the
possibility  of  improving  the  drug  metabolism  and  transport  capability  of
human liver cell lines with 3D hydrogels.
Figure 8 Only highly polarized hepatocytes express vectorial transport from sinusoidal
membrane to the bile canaliculi. Here we present new 3D liver cell cultures that
differ from the standard 2D liver cell cultures by improved polarity and vectorial
transport. The 3D spheroid cultures have potential applicability in drug metabolism,
transport and toxicity studies hereby facilitating the drug discovery.
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